-
ANN HEMATOL 2024 10.1007/s00277-024-06035-w
Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices
Lee, J; Yoon, SE; Kim, SJ; Kim, WS; Cho, J
View PubMed
-
EXP CELL RES 2024 10.1016/j.yexcr.2024.114248
Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma
Park, B; Choi, ME; Ryu, KJ; Park, C; Choi, M; Yoon, SE; Kim, WS; Kim, HH; Hong, JY; Kim, SJ
View PubMed
-
CANCER TREAT REV 2024 10.1016/j.ctrv.2024.102793
Peripheral T-cell lymphoma: From biology to practice to the future
O'Connor, OA; Ma, H; Chan, JYS; Kim, SJ; Yoon, SE; Kim, WS
View PubMed
-
ANN HEMATOL 2024 10.1007/s00277-024-05907-5
Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea
Kim, SJ; Yoon, SY; Chua, S; Byun, H; Kim, J; Ng, J
View PubMed
-
BLOOD 2024 10.1182/blood.2023023419
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis
Kim, J; Cho, J; Lee, MH; Yoon, SE; Kim, WS; Kim, SJ
View PubMed
-
BRIT J HAEMATOL 2024 10.1111/bjh.19659
Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma
Yi, JH; Kim, SJ; Yang, DH; Do, YR; Won, JH; Baek, D; Shin, HJ; Kim, DS; Kim, HJ; Kang, KW; Bae, SH; Kwon, JH; Kwon, JH; Park, BB; Kim, WS
View PubMed
-
TRANSPL INFECT DIS 2024 10.1111/tid.14328
QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation
Yoon, E; Shin, S; Choi, S; Jang, JH; Kim, K; Kim, SJ; Kim, WS; Jung, CW; Kang, ES
View PubMed
-
ANN HEMATOL 2024 10.1007/s00277-024-05902-w
Long-term survival outcomes of 'watch and wait' in patients with bronchus-associated lymphoid tissue lymphoma: a multicenter real-world data analysis in Korea
Kwak, K; Yoo, KH; Choi, YS; Park, Y; Kim, BS; Yoon, SE; Kim, WS; Kang, KW; Kim, SJ
View PubMed
-
CANCER RES TREAT 2024 10.4143/crt.2023.869
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Yoon, SE; Shin, SH; Nam, DK; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
ANN HEMATOL 2024 10.1007/s00277-024-05739-3
Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma
Yoon, SE; Cho, H; Berning, P; Cho, J; Kim, HY; Yoon, DH; Schmit, N; Kim, SJ; Kim, WS
View PubMed
-
ANN LAB MED 2024 10.3343/alm.2023.0388
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies
Kim, SJ; Yoon, SE; Kim, WS
View PubMed
-
ACTA HAEMATOL-BASEL 2024 10.1159/000537962
Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma: Real-World Experience
Choi, DH; Yoon, SE; Cho, JH; Kim, SJ; Kim, WS
View PubMed
-
CANCER RES TREAT 2024 10.4143/crt.2023.1042
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea
Lee, JY; Kwon, JH; Hur, JY; Yi, JH; Lee, JH; Cho, H; Do, YR; Jo, JC; Kang, HJ; Koh, Y; Lee, WS; Lim, SN; Yoon, SE; Kim, SJ; Lee, JO
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2023.1194315
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma
Yoon, SE; Park, S; Cho, J; Ryu, KJ; Yandava, B; Lee, S; Kim, SJ; Kim, WS
View PubMed
-
BLOOD ADV 2023 10.1182/bloodadvances.2023010298
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
Nastoupil, LJ; Hess, G; Pavlovsky, MA; Danielewicz, I; Freeman, J; Garcia-Sancho, AM; Glazunova, V; Grigg, A; Hou, JZ; Janssens, A; Kim, SJ; Masliak, Z; Mckay, P; Merli, F; Munakata, W; Nagai, H; Özcan, M; Preis, M; Wang, TY; Rowe, M; Tamegnon, M; Cir, R; Henninger, T; Curtis, M; Caces, DB; Thieblemont, C; Salles, G
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2023.1230629
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
Kim, SJ; Jo, JC; Yoon, DH; Yang, DH; Yoon, SE; Lee, GW; Kong, JH; Park, Y; Kang, KW; Lee, HS; Oh, SY; Shin, HJ; Lee, WS; Choi, YS; Jeong, SH; Kim, MK; Kang, HJ; Yi, JH; Lim, SN; Yhim, HY; Do, YR; Yun, HJ; Eom, HS; Lee, MH; Suh, C; Kim, WS
View PubMed
-
BLOOD CANCER J 2023 10.1038/s41408-023-00889-5
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
Park, S; Kim, JH; Kim, S; Kang, J; Moon, S; Kim, SJ; Shin, JY
View PubMed
-
SCI REP-UK 2023 10.1038/s41598-023-37742-5
Clinical relevance of deep learning models in predicting the onset timing of cancer pain exacerbation
Bang, YH; Choi, YH; Park, M; Shin, SY; Kim, SJ
View PubMed
-
BMC MED IMAGING 2023 10.1186/s12880-023-01054-x
Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis
Park, YJ; Lee, JH; Kim, D; Choi, JO; Kim, SJ; Kim, K; Choi, JY
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.1658
Efficacy of Salvage Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Including Chimeric Antigen Receptor T-Cell Therapy: A Systematic Review and Meta-Analysis
Kim, J; Cho, JHY; Yoon, SE; Kim, WS; Kim, SJ
View PubMed
-
CANCER MANAG RES 2023 10.2147/CMAR.S407837
Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma
Lee, YP; Yoon, SE; Cho, J; Ko, YH; Oh, D; Ahn, YC; Kim, WS; Kim, SJ
View PubMed
-
CANCER MED-US 2023 10.1002/cam4.6268
A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B-cell lymphoma
Lee, H; Yoon, SE; Kim, SJ; Kim, WS; Cho, JH
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2023.1186311
Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment
Jin, HY; Jin, MY; Lim, CH; Choi, JY; Kim, SJ; Lee, KH
View PubMed
-
BLOOD CANCER J 2023 10.1038/s41408-023-00868-w
Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
Baek, DW; Moon, JH; Lee, JH; Kang, KW; Lee, HS; Eom, HS; Lee, ENY; Lee, JH; Lee, JO; Park, SK; Kim, SJ; Yoo, KH; Yoon, SS; Koh, Y; Kang, HJ; Won, JH; Lyu, CJ; Hahn, SM; Lee, JH; Park, JS; Jo, JC; Mun, YC; Yang, DH; Song, GY; Lim, SN; Sohn, SK
View PubMed
-
NEW ENGL J MED 2023 10.1056/NEJMoa2303379
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
San-Miguel, J; Dhakal, B; Yong, K; Spencer, A; Anguille, S; Mateos, MV; de Larrea, CF; Martinez-Lopez, J; Moreau, P; Touzeau, C; Leleu, X; Avivi, I; Cavo, M; Ishida, T; Kim, SJ; Roeloffzen, W; van de Donk, NWCJ; Dytfeld, D; Sidana, S; Costa, LJ; Oriol, A; Popat, R; Khan, AM; Cohen, YC; Ho, PJ; Griffin, J; Lendvai, N; Lonardi, C; Slaughter, A; Schecter, JM; Jackson, CC; Connors, K; Li, K; Zudaire, E; Chen, DN; Gilbert, J; Yeh, T; Nagle, S; Florendo, E; Pacaud, L; Patel, N; Harrison, SJ; Einsele, H
View PubMed
-
BLOOD 2023 10.1182/blood.2022018831
The influence of microbial dysbiosis on immunochemotherapy-related efficacy and safety in diffuse large B-cell lymphoma
Yoon, SE; Kang, W; Choi, S; Park, Y; Chalita, M; Kim, H; Lee, JH; Hyun, DW; Ryu, KJ; Sung, H; Lee, JY; Bae, JW; Kim, WS; Kim, SJ
View PubMed
-
ANN HEMATOL 2023 10.1007/s00277-023-05182-w
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma
Jeon, Y; Yoon, SE; Cho, JH; Kim, SJ; Kim, WS
View PubMed
-
KOREAN CIRC J 2023 10.4070/kcj.2022.0356
A Novel Transthyretin Gene Mutation in Hereditary Transthyretin Amyloidosis: A Case Series of Met13dup Patients
Jeon, K; Kim, D; Park, M; Choi, JO; Kim, K; Kim, SJ; Kim, JS; Jeon, ES
View PubMed
-
J NEURO-ONCOL 2023 10.1007/s11060-023-04337-z
A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study
Wei, L; Gao, YT; Prochazka, KT; Liu, RQ; Wang, L; Liu, BY; He, YZ; Bertero, L; Pellerino, A; Cassoni, P; Tamagnone, L; Deutsch, AJ; Zhan, HE; Lai, J; Kim, SJ; You, H
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.1434
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
Cho, HYW; Yoon, DH; Shin, DY; Koh, Y; Yoon, SS; Kim, SJ; Do, YR; Lee, GW; Kwak, JY; Park, Y; Kim, MK; Kang, HJ; Yi, JH; Yoo, KH; Lee, WS; Park, BB; Jo, JC; Eom, HS; Kim, HJ; Jeong, SH; Won, YW; Sohn, BS; Kwon, JH; Suh, C; Kim, WS
View PubMed
-
FRONT IMMUNOL 2023 10.3389/fimmu.2023.1139980
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
Yang, J; Won, G; Baek, JY; Lee, YH; Kim, H; Huh, K; Cho, SY; Kang, CI; Chung, DR; Peck, KR; Lee, KW; Park, JB; Yoon, SE; Kim, SJ; Kim, WS; Yim, MS; Kim, K; Hyeon, S; Kim, BC; Lee, YK; Ko, JH
View PubMed
-
CANCER-AM CANCER SOC 2023 10.1002/cncr.34698
TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients
Cho, J; Kim, E; Yoon, SE; Kim, SJ; Kim, WS
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2023.1109715
In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
Kim, JJ; Kim, HY; Choi, Z; Hwang, SY; Jeong, H; Choi, JR; Yoon, SE; Kim, WS; Kim, SH; Kim, HJ; Shin, SY; Lee, ST; Kim, SJ
View PubMed
-
CL LYMPH MYELOM LEUK 2023 10.1016/j.clml.2022.10.010
Single Center Experience of Autologous Stem Cell Transplantation in Patients with Systemic Light Chain Amyloidosis in Korea
Kim, HR; Yoon, SE; Kim, D; Choi, JO; Min, JH; Kim, BJ; Kim, JS; Lee, JE; Choi, JY; Jeon, ES; Kim, SJ; Kim, K
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.017
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Kim, SJ; Kim, YJ; Yoon, SE; Ryu, KJ; Park, B; Park, D; Cho, D; Kim, HY; Cho, J; Ko, YH; Park, WY; Kim, WS
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.015
A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma: Incorporation of Serum beta-2 Microglobulin to PINK
Kang, S; Cho, H; Kim, S; Lee, K; Kang, EH; Park, JS; Lee, YS; Park, CS; Go, H; Huh, J; Ryu, JS; Lee, SW; Kim, SJ; Kim, WS; Yoon, SE; Ko, YH; Suh, C
View PubMed
-
VIRCHOWS ARCH 2023 10.1007/s00428-023-03493-x
Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma
Lee, J; Han, JH; Lee, CH; Park, HS; Min, SK; Lee, H; Cho, U; Yoon, SE; Kim, SJ; Kim, WS; Cho, JH
View PubMed
-
FRONT ONCOL 2023 10.3389/fonc.2022.1071281
Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
Jeong, SY; Yoon, SE; Cho, D; Kang, ES; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.008
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
Yi, JH; Jeong, SH; Kim, SJ; Yoon, DH; Kang, HJ; Koh, Y; Kim, JS; Lee, WS; Yang, DH; Do, YR; Kim, MK; Yoo, KH; Choi, YS; Yun, WJ; Park, Y; Jo, JC; Eom, HS; Kwak, JY; Shin, HJ; Park, BB; Yi, SY; Kwon, JH; Oh, SY; Kim, HJ; Sohn, BS; Won, JH; Hong, DS; Lee, HS; Lee, GW; Suh, C; Kim, WS
View PubMed
-
INT J HEMATOL 2022 10.1007/s12185-022-03525-3
A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea
Yoon, SE; Kim, D; Choi, JO; Min, JH; Kim, BJ; Kim, JS; Lee, JE; Choi, JY; Jeon, ES; Kim, SJ; Kim, K
View PubMed
-
BLOOD ADV 2022 10.1182/bloodadvances.2021006305
CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain
Cho, J; Yoon, SE; Kim, SJ; Ko, YH; Kim, WS
View PubMed
-
ANTICANCER RES 2022 10.21873/anticanres.16120
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
Yi, JH; Kim, SJ; Lee, JO; Lee, GW; Kwak, JY; Eom, HS; Jo, JC; Choi, YS; Oh, SY; Kim, WS
View PubMed
-
CANCERS 2022 10.3390/cancers14225618
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
Kim, SJ; Ryu, KJ; Park, B; Yoon, SE; Cho, J; Park, Y; Kim, WS
View PubMed
-
CL LYMPH MYELOM LEUK 2022 10.1016/j.clml.2022.07.009
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma
Yoon, SE; Cho, J; Kim, YJ; Kim, SJ; Kim, WS
View PubMed
-
CANCER RES TREAT 2022 10.4143/crt.2021.1168
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged >= 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
Jeong, SH; Kim, SJ; Yoon, DH; Park, Y; Kang, HJ; Koh, Y; Lee, GW; Lee, WS; Yang, DH; Do, YR; Kim, MK; Yoo, KH; Choi, YS; Yun, HJ; Yi, JH; Jo, JC; Eom, HS; Kwak, JY; Shin, HJ; Park, BB; Hyun, SY; Yi, SY; Kwon, JH; Oh, SY; Kim, HJ; Sohn, BS; Won, JH; Kim, SH; Lee, HS; Suh, C; Kim, WS
View PubMed
-
ANN LAB MED 2022 10.3343/alm.2022.42.5.558
Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
Kim, HY; Yoo, IY; Lim, DJ; Kim, HJ; Kim, SH; Yoon, SE; Kim, SJ; Cho, D; Kim, K
View PubMed
-
J ONCOL 2022 10.1155/2022/2263217
Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data Analysis
Lee, YP; Lee, MS; Yoon, SE; Cho, JH; Bang, YH; Shim, JH; Kim, WS; Kim, SJ
View PubMed
-
SCI REP-UK 2022 10.1038/s41598-022-16562-z
Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilization
Yi, HK; Yoo, J; Kim, SJ; Choi, JY; Lee, KH
View PubMed
-
AMYLOID 2022 10.1080/13506129.2022.2082866
Generalised autonomic failure as a prognostic factor in systemic light-chain (AL) amyloidosis
Kwon, S; Jeong, WK; Park, JH; Kim, J; Cho, EB; Seok, JM; Kim, SJ; Kim, K; Jeon, ES; Min, JH; Kim, BJ
View PubMed
-
NEW ENGL J MED 2022 10.1056/NEJMoa2201817
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Wang, MCL.; Jurczak, W; Jerkeman, M; Trotman, J; Zinzani, PL; Belada, D; Boccomini, C; Flinn, IW; Giri, P; Goy, A; Hamlin, PA; Hermine, O; Hernandez-Rivas, JA; Hong, XA; Kim, SJ; Lewis, D; Mishima, Y; Ozcan, M; Perini, GF; Pocock, C; Song, YQ; Spurgeon, SE; Storring, JM; Walewski, J; Zhu, J; Qin, R; Henninger, T; Deshpande, S; Howes, A; Le Gouill, S; Dreyling, M
View PubMed
-
FRONT CARDIOVASC MED 2022 10.3389/fcvm.2022.904878
Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
Bak, M; Kim, D; Choi, JO; Kim, K; Kim, SJ; Jeon, ES
View PubMed
-
ANN HEMATOL 2022 10.1007/s00277-022-04805-y
Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma
Lee, YP; Yoon, SE; Cho, J; Ko, YH; Jo, H; Kim, SJ; Kim, WS
View PubMed
-
CANCER RES TREAT 2022 10.4143/crt.2021.752
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma
Yoon, SE; Kim, YJ; Shim, JH; Park, D; Cho, J; Ko, YH; Park, WY; Mun, YC; Lee, KE; Cho, D; Kim, WS; Kim, SJ
View PubMed
-
BONE MARROW TRANSPL 2022 10.1038/s41409-022-01605-w
Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis
Yoon, SE; Jo, H; Kang, ES; Cho, D; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
MOL THER 2022 10.1016/j.ymthe.2021.10.004
PD-1 and TIGIT downregulation distinctly affect the effector and early memory phenotypes of CD19-targeting CAR T cells
Lee, YH; Lee, HJ; Kim, HC; Lee, Y; Nam, SK; Hupperetz, C; Ma, JSY; Wang, XX; Singer, O; Kim, WS; Kim, SJ; Koh, Y; Jung, I; Kim, CH
View PubMed
-
J CANCER 2022 10.7150/jca.69639
Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma
Bang, YH; Shim, JH; Ryu, KJ; Kim, YJ; Choi, ME; Yoon, SE; Cho, J; Park, B; Park, WY; Kim, WS; Kim, SJ
View PubMed
-
JACC CARDIOVASC IMAGING 2021 2021
Association of Left Ventricular Global Longitudinal Strain With Cardiac Amyloid Load in Light Chain Amyloidosis
Kim1, D; Choi, JO; Kim, K; Kim, SJ; Kim, JS; Jeon, ES
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.669817 2021
Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
Lee1, BH; Park, Y; Kim, JH; Kang, KW; Lee, SJ; Kim, SJ; Kim, BS
View PubMed
-
CANCER MANAG RES 2021 10.2147/CMAR.S309092 2021
Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma
Lee1, YP; Hong, JY; Yoon, SE; Cho, J; Shim, JH; Bang, Y; Kim, WS; Kim, SJ
View PubMed
-
EXP HEMATOL ONCOL 2021 10.1186/s40164-021-00224-3 2021
Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas
Yoon1, SE; Cho, J; Kim, YJ; Ko, YH; Park, WY; Kim, SJ; Kim, WS
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-89754-8 2021
EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma
Lee1, JY; Kim, JH; Bang, H; Cho, J; Ko, YH; Kim, SJ; Kim, WS
View PubMed
-
KOREAN J INTERN MED 2021 10.3904/kjim.2019.367 2021
Real-world data on the survival outcome of patients with newly diagnosed Waldenstrom macroglobulinemia
Cho1, JH; Shim, JH; Yoon, SE; Kim, HJ; Kim, SH; Ko, YH; Lee, ST; Kim, K; Kim, WS; Kim, SJ
View PubMed
-
ANN ONCOL 2021 10.1016/j.annonc.2020.12.009 2021
Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial
Yhim1, HY; Kim, T; Kim, SJ; Shin, HJ; Koh, Y; Kim, JS; Park, J; Park, GS; Kim, WS; Moon, JH; Yang, DH
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-88815-2 2021
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation
Park1, YJ; Hyun, SH; Moon, SH; Lee, KH; Min, BH; Lee, JH; Kim, WS; Kim, SJ; Choi, JY
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-85332-0 2021
Metabolic activity of extranodal NK/T cell lymphoma on F-18-FDG PET/CT according to immune subtyping
Lim1, CH; Yoon, SE; Kim, SJ; Cho, J; Ko, YH; Lee, KH; Kim, WS
View PubMed
-
J CANCER 2021 10.7150/jca.55553 2021
Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis
Lee1, JY; Ryu, D; Lim, SW; Ryu, KJ; Choi, ME; Yoon, SE; Kim, K; Park, C; Kim, SJ
View PubMed
-
J CANCER 2021 10.7150/jca.54434 2021
Impact of transformation on the survival of patients diagnosed with follicular lymphoma that progressed within 24 months
Yoon1, SE; Cho, J; Kim, WS; Kim, SJ
View PubMed
-
CANCER COMMUN 2021 10.1002/cac2.12150 2021
Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
Yi1, JH; Kim, SJ; Yoon, DH; Suh, C; Chang, MH; Yang, DH; Jo, JC; Hyun, SY; Eom, HS; Lee, JO; Kwon, JH; Han, SH; Lee, SS; Kwak, JY; Kim, SH; Kim, DS; Lee, JH; Oh, SY; Ryoo, HM; Kim, HJ; Kim, WS
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.628807 2021
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Lee1, B; Lee, H; Cho, J; Yoon, SE; Kim, SJ; Park, WY; Kim, WS; Ko, YH
View PubMed
-
SUPPORT CARE CANCER 2021 10.1007/s00520-021-06017-y 2021
Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma
Kim1, SJ; Kang, D; Park, Y; Mun, YC; Kim, K; Kim, JS; Min, CK; Cho, J
View PubMed
-
BMC CANCER 2021 10.1186/s12885-021-07806-8 2021
The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma
Kang1, JH; Lee, SH; Lee, J; Choi, M; Cho, J; Kim, SJ; Kim, WS; Ko, YH; Yoo, HY
View PubMed
-
BLOOD CANCER J 2021 10.1038/s41408-021-00595-0
Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study
Kang, D; Yoon, SE; Shin, D; Lee, J; Hong, YS; Lee, SK; Lee, JE; Park, YH; Ahn, JS; Guallar, E; Kim, WS; Lee, J; Kim, SJ; Cho, J
View PubMed
-
J NEURO-ONCOL 2021 10.1007/s11060-021-03909-1
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma
Kim, N; Lim, DH; Yoon, SE; Kim, SJ; Kim, WS
View PubMed
-
ANN LAB MED 2021 10.3343/alm.2021.41.6.593
A Case of Burkitt-Like Lymphoma With 11q Aberration With HIV Infection in East Asia and Literature Review
Kim, JA; Kim, HY; Kim, SJ; Kim, HJ; Kim, SH
View PubMed
-
CANCERS 2021 10.3390/cancers13194760
Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study
Kang, J; Jin, SM; Kim, SJ; Kim, D; Han, K; Jeong, SM; Chang, J; Rhee, SY; Choi, T; Shin, DW
View PubMed
-
LEUKEMIA LYMPHOMA 2021 10.1080/10428194.2021.1971220
Prognostic significance of serum beta 2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified
Kim, HD; Cho, H; Sohn, BS; Park, CS; Huh, J; Ryu, JS; Lee, SW; Yoon, SE; Kim, SJ; Ko, YH; Kim, WS; Suh, C
View PubMed
-
ANAL CHEM 2021 10.1021/acs.analchem.1c01722
tipNrich: A Tip-Based N-Terminal Proteome Enrichment Method
Lee, S; Ju, S; Kim, SJ; Choi, JO; Kim, K; Kim, D; Jeon, ES; Lee, C
View PubMed
-
BRIT J HAEMATOL 2021 10.1111/bjh.17898
Clinical trial participation improves survival outcomes by increasing availability of new therapeutic agents in multiple myeloma
Jung, SH; Lee, JJ; Song, GY; Lee, HS; Kim, SJ; Yoon, SE; Kim, K
View PubMed
-
ESC HEART FAIL 2021 10.1002/ehf2.13604
Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
Kim, D; Choi, JO; Kim, K; Kim, SJ; Kim, JS; Jeon, ES
View PubMed
-
HEMATOL ONCOL 2021 10.1002/hon.2924
Comparison of first-line treatments of peripheral T-cell lymphoma according to regimen: A systematic review and meta-analysis
Kim, J; Cho, J; Byeon, S; Kim, WS; Kim, SJ
View PubMed
-
CANCER MANAG RES 2021 10.2147/CMAR.S330308
Imaging Features and Prognostic Value of FDG PET/CT in Patients with Intravascular Large B-Cell Lymphoma
Lim, CH; Yoon, SE; Kim, WS; Lee, KH; Kim, SJ
View PubMed
-
BMC CANCER 2021 10.1186/s12885-021-08695-7
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
Cho, J; Yoon, SE; Kim, SJ; Ko, YH; Kim, WS
View PubMed
-
FRONT ONCOL 2021 10.3389/fonc.2021.696147
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups
Gao, YT; Wei, L; Kim, SJ; Wang, L; He, YZ; Zheng, YF; Bertero, L; Pellerino, A; Cassoni, P; Tamagnone, L; Theresa, PK; Deutsch, A; Zhan, HE; Lai, J; Wang, Y; You, H
View PubMed
-
J NEURO-ONCOL 2021 10.1007/s11060-021-03815-6
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapy
Kim, N; Lim, HD; Yoon, SE; Kim, SJ; Kim, WS
View PubMed
-
INT J HEMATOL 2021 10.1007/s12185-021-03179-7
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia
Lee, YP; Yoon, SE; Song, YQ; Kim, SJ; Yoon, DH; Chen, TY; Koh, YI; Kang, KW; Lee, HS; Wei, KTK; Lim, ST; Poon, M; Irawan, C; Zhao, WL; Do, YR; Lee, MH; Ng, SC; Lee, WS; Guo, Y; Zhang, HL; Kang, HJ; Yun, HJ; Kim, HJ; Lung, DTC; Kwak, JY; Han, JJ; Mun, YC; Oh, SY; Shim, H; Kwon, JH; Sohn, BS; Park, SK; Jo, JC; Ko, YH; Jun, Z; Kim, WS
View PubMed
-
J CLIN APHERESIS 2021 10.1002/jca.21924
Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34(+) cell counts differs according to diagnosis in patients undergoing autologous peripheral blood stem cell transplantation
Kim, SM; Kim, HY; Kim, SJ; Jang, JH; Kim, K; Kim, WS; Jung, CW; Cho, D; Kang, ES
View PubMed
-
ANN HEMATOL 2021 10.1007/s00277-021-04558-0
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study
Kim, WS; Oki, Y; Kim, SJ; Yoon, SE; Ardeshna, KM; Lin, Y; Ruan, J; Porcu, P; Brammer, JE; Jacobsen, ED; Yoon, DH; Suh, C; Suarez, F; Radford, J; Budde, LE; Kim, JS; Bachy, E; Lee, HJ; Bollard, CM; Jaccard, A; Kang, HJ; Inman, S; Murray, M; Combs, KE; Lee, DIY; Advani, R; Gunter, KC; Rooney, CM; Heslop, HE
View PubMed
-
CANCER RES TREAT 2021 10.4143/crt.2020.1060
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum beta 2-microglobulin Levels
Kim, HD; Cho, H; Kim, S; Lee, K; Kang, EH; Park, JS; Park, CS; Huh, J; Ryu, JS; Lee, SW; Yoon, DH; Kim, SJ; Ko, YH; Kim, WS; Suh, C
View PubMed
-
BLOOD 2020 2020
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma an open-label phase 2 study
Kim1, SJ; Lim, JQ; Laurensia, Y; Cho, J; Yoon, SE; Lee, JY; Ryu, KJ; Ko, YH; Koh, Y; Cho, D; Lim, ST; Enemark, MB; D'amore, F; Bjerre, M; Ong, CK; Kim, WS
View PubMed
-
CANCERS 2020 10.3390/cancers12123548 2020
Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma
Ryu1, KJ; Lee, JY; Choi, ME; Yoon, SE; Cho, J; Ko, YH; Shim, JH; Kim, WS; Park, C; Kim, SJ
View PubMed
-
LEUKEMIA 2020 10.1038/s41375-020-01081-5 2020
Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy
Jeong1, SM; Choi, T; Kim, D; Han, K; Kim, SJ; Rhee, SY; Giovannucci, EL; Shin, DW
View PubMed
-
BONE MARROW TRANSPL 2020 10.1038/s41409-020-01160-2 2020
Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma
Song1, GY; Yoon, DH; Suh, C; Moon, JH; Baek, DW; Kim, JS; Lee, GW; Yi, JH; Park, Y; Jung, KS; Kim, SJ; Yang, DH; Kim, WS
View PubMed
-
APPL IMMUNOHISTOCHEM MOL MORPHOL 2020 10.1097/PAI.0000000000000843 2020
Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified
Cho1, I; Yoon, N; Hyeon, J; Sim, J; Yoo, HY; Kim, SJ; Kim, WS; Ko, YH
View PubMed
-
BLOOD 2020 10.1182/blood.2020005026 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma
Kim1, H; Jeong, H; Yamaguchi, M; Sohn, I; Yoon, SE; Byeon, S; Hur, JY; Koh, Y; Yoon, SS; Kim, EJ; Oguchi, M; Miyazaki, K; Taguchi, S; Yoon, DH; Cho, J; Ko, YH; Kim, SJ; Suzuki, R; Kim, WS
View PubMed
-
BLOOD ADV 2020 10.1182/bloodadvances.2020002814 2020
A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score
Yhim1, HY; Eshet, Y; Metser, U; Lim, CH; Lajkosz, K; Isaev, K; Cooper, M; Prica, A; Kukreti, V; Bhella, S; Lang, N; Lee, KH; Xu, W; Hodgson, D; Tsang, R; Yoon, SE; Kim, SJ; Kim, WS; Crump, M; Kuruvilla, J; Kridel, R
View PubMed
-
ANN LAB MED 2020 10.3343/alm.2020.40.5.409 2020
Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis
Yoo1, IY; Bang, SH; Lim, DJ; Kim, SJ; Kim, K; Kim, HJ; Kim, SH; Cho, D
View PubMed
-
PATIENT EDUC COUNS 2020 10.1016/j.pec.2020.03.007 2020
Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners
Kim1, IR; Jang, SY; Shin, HS; Choi, HJ; Jung, CW; Yoon, SS; Kim, JS; Kim, SJ; Kim, K; Kim, WS; Lee, CH; Kang, D; Cho, J
View PubMed
-
CANCERS 2020 10.3390/cancers12082192 2020
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis A Multicenter Phase 2 Trial
Yhim1, HY; Yoon, DH; Kim, SJ; Yang, DH; Eom, HS; Ha Kim, K; Park, Y; Kim, JS; Kim, HJ; Suh, C; Kim, WS; Kwak, JY
View PubMed
-
LEUKEMIA 2020 10.1038/s41375-020-1000-0 2020
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
Lim1, JQ; Huang, DC; Tang, T; Tan, D; Laurensia, Y; Peng, RJ; Wong, EKY; Cheah, DMZ; Chia, BKH; Iqbal, J; Grigoropoulos, NF; Nairismagi, ML; Ng, CCY; Rajasegaran, V; Hong, HM; Kim, SJ; Cho, J; Tse, E; Mow, B; Cai, QC; Poon, L; Cai, QQ; Tan, J; Chan, JY; Lim, JX; Goh, YT; Phipps, C; Rotzschke, O; Cheng, CL; Ha, JCH; Khoo, LP; Loh, YSM; Au-Yeung, R; Chan, TSY; Kwong, YL; Hwang, W; Kim, WS; Bei, JX; Lin, TY; Ong, CK; Lim, ST
View PubMed
-
BMC CANCER 2020 10.1186/s12885-020-07317-y 2020
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
Song1, GY; Jung, SH; Kim, K; Kim, SJ; Yoon, SE; Lee, HS; Kim, M; Ahn, SY; Ahn, JS; Yang, DH; Kim, HJ; Lee, JJ
View PubMed
-
KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.396 2020
Asian variant of intravascular large B-cell lymphoma a comparison of clinical features based on involvement of the central nervous system
Yoon1, SE; Kim, WS; Kim, SJ
View PubMed
-
SCI REP-UK 2020 10.1038/s41598-020-69616-5 2020
PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis developing a nomogram-based prognostic model
Lee1, BH; Park, Y; Kim, JH; Kang, KW; Lee, SJ; Kim, SJ; Kim, BS
View PubMed
-
BMC CANCER 2020 10.1186/s12885-020-07102-x 2020
Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization
Kang1, KW; Lee, SJ; Kim, JH; Lee, BH; Kim, SJ; Park, Y; Kim, BS
View PubMed
-
SCI REP-UK 2020 10.1038/s41598-020-68310-w 2020
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
Song1, GY; Yoon, SE; Kim, SJ; Kim, JS; Koh, Y; Moon, JH; Oh, SY; Lee, HS; Shin, HJ; Do, YR; Lee, WS; Kim, DS; Park, Y; Yhim, HY; Yang, DH
View PubMed
-
ANN HEMATOL 2020 10.1007/s00277-020-04008-3 2020
Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas
Hur1, JY; Kim, YJ; Yoon, SE; Son, DS; Park, WY; Kim, SJ; Park, D; Kim, WS
View PubMed
-
ANN HEMATOL 2020 10.1007/s00277-020-04005-6 2020
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis
Yoon1, SE; Kim, SJ; Yoon, KH; Koh, Y; Mun, YC; Do, YR; Choi, YS; Yang, DH; Kim, MK; Lee, GW; Suh, C; Ko, YH; Kim, WS
View PubMed
-
CYTOKINE 2020 10.1016/j.cyto.2020.155048 2020
Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma
Yi1, JH; Yoon, SE; Ryu, KJ; Ko, YH; Kim, WS; Kim, SJ
View PubMed
-
ANN HEMATOL 2020 10.1007/s00277-020-04083-6 2020
A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study
Yoon1, SE; Eun, Y; Huh, K; Chung, CR; Yoo, IY; Cho, J; Cho, D; Ko, YH; Park, S; Kim, WS; Kim, SJ
View PubMed
-
ANN LAB MED 2020 10.3343/alm.2020.40.3.253 2020
Isolation of Small Extracellular Vesicles From Human Serum Using a Combination of Ultracentrifugation With Polymer-Based Precipitation
Ryu1, KJ; Lee, JY; Park, C; Cho, D; Kim, SJ
View PubMed
-
Lancet Haematol 2020 10.1016/S2352-3026(19)30283-2 2020
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
Fox1, CP; Civallero, M; Ko, YH; Manni, M; Skrypets, T; Pileri, S; Kim, SJ; Cabrera, ME; Shustov, AR; Chiattone, CS; Horwitz, SM; Dlouhy, I; Spina, M; Hitz, F; Montoto, S; Nagler, A; Martinez, V; De Souza, CA; Fernandez-Alvarez, R; Ballova, V; Gabus, R; Inghirami, G; Federico, M; Kim, WS
View PubMed
-
MODERN PATHOL 2020 10.1038/s41379-019-0392-8 2020
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression
Cho1, J; Kim, SJ; Park, WY; Kim, J; Woo, J; Kim, G; Yoon, SE; Ko, YH; Kim, WS
View PubMed
-
CANCER RES TREAT 2020 10.4143/crt.2019.198 2020
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
Kim1, SJ; Yoon, DH; Kim, JS; Kang, HJ; Lee, HW; Eom, HS; Hong, JY; Cho, J; Ko, YH; Huh, J; Yang, WI; Park, WS; Lee, SS; Suh, C; Kim, WS
View PubMed
-
BLOOD ADV 2020 10.1182/bloodadvances.2019001114 2020
Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk
Witalis1, M; Chang, J; Zhong, MC; Bouklouch, Y; Panneton, V; Li, JN; Buch, T; Kim, SJ; Kim, WS; Ko, YH; Veillette, A; Suh, WK
View PubMed
-
INVEST NEW DRUG 2020 10.1007/s10637-020-00916-3 2020
Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
Kroschinsky1, F; Middeke, JM; Janz, M; Lenz, G; Witzens-Harig, M; Bouabdallah, R; La Rosee, P; Viardot, A; Salles, G; Kim, SJ; Kim, TM; Ottmann, O; Chromik, J; Quinson, AM; von Wangenheim, U; Burkard, U; Berk, A; Schmitz, N
View PubMed
-
J HEMATOL ONCOL 2020 10.1186/s13045-020-00855-9 2020
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
Yoon1, DH; Cao, JN; Chen, TY; Izutsu, K; Kim, SJ; Kwong, YL; Lin, TY; Thye, LS; Xu, B; Yang, DH; Kim, WS
View PubMed
-
BMC CANCER 2020 10.1186/s12885-020-6612-2 2020
Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma
Cho1, I; Lee, H; Yoon, SE; Ryu, KJ; Ko, YH; Kim, WS; Kim, SJ
View PubMed
-
CLIN CANCER RES 2020 10.1158/1078-0432.CCR-19-0694 2020
Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion
Ryu1, D; Kim, SJ; Hong, Y; Jo, A; Kim, N; Kim, HJ; Lee, HO; Kim, K; Park, WY
View PubMed
-
ANN HEMATOL 2020 10.1007/s00277-019-03891-9 2020
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma
Won1, YW; Lee, H; Eom, HS; Kim, JS; Suh, C; Yoon, DH; Hong, JY; Kang, HJ; Lee, JH; Kim, WS; Kim, SJ; Lee, WS; Chang, MH; Do, YR; Yi, JH; Kim, I; Won, JH; Kim, K; Oh, SY; Jo, JC
View PubMed
-
ANN HEMATOL 2020 10.1007/s00277-019-03803-x 2020
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report
Jo1, JC; Kim, SJ; Lee, HS; Eom, HS; Lee, SI; Park, Y; Lee, JO; Lee, Y; Yhim, HY; Yang, DH; Byun, JM; Kang, HJ; Kim, HJ; Shin, HJ; Yoo, KH; Suh, C
View PubMed
-
PSYCHO-ONCOL 2020 10.1002/pon.5265 2020
Impact of fear of cancer recurrence on survival among lymphoma patients
Kim1, SJ; Kang, D; Kim, IR; Yoon, SE; Kim, WS; Butow, PN; Guallar, E; Cho, J
View PubMed
-
J AM COLL CARDIOL 2020 10.1016/j.jacc.2019.11.045 2020
Prognostic Value of the Index of Microcirculatory Resistance Over Serum Biomarkers in Cardiac Amyloidosis
Choi1, KH; Lee, JM; Kim, SR; Kim, D; Choi, JO; Kim, SJ; Kim, K; Kim, JS; Koo, BK; Jeon, ES
View PubMed
-
MEDICINE 2020 10.1097/MD.0000000000018905 2020
Tc-99m-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis Potential clinical implications
Lee1, JH; Kim, K; Choi, JO; Kim, SJ; Jeon, ES; Choi, JY
View PubMed
-
AM J HEMATOL 2020 10.1002/ajh.25726 2020
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
Lee1, HS; Kim, K; Kim, SJ; Lee, JJ; Kim, I; Kim, JS; Eom, HS; Yoon, DH; Suh, C; Shin, HJ; Mun, YC; Kim, MK; Lim, SN; Choi, CW; Kang, HJ; Yoon, SS; Min, CK
View PubMed
-
RESP MED 2020 10.1016/j.rmed.2019.105853 2020
Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors
Im1, Y; Lee, J; Kim, SJ; Koh, WJ; Jhun, BW; Lee, SH
View PubMed
-
KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.196 2020
Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
Kim1, HK; Kang, W; Sinn, DH; Lee, JH; Kim, WS; Kim, SJ
View PubMed
-
ANN LAB MED 2020 10.3343/alm.2020.40.1.88 2020
Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults
Choi1, S; Kim, YJ; Yoo, KH; Sung, KW; Koo, HH; Kim, SJ; Jang, JH; Kim, K; Jung, CW; Huh, HJ; Kang, ES
View PubMed
-
BONE MARROW TRANSPL 2019 10.1038/s41409-019-0629-7 2019
Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
Lee1, YJ; Moon, JH; Sohn, SK; Kim, SJ; Jung, SH; Lee, JJ; Jo, JC; Shin, HJ; Lee, WS; Lee, JH; Bae, SH; Kim, MK; Lee, HS; Kim, K; Min, CK
View PubMed
-
ANN HEMATOL 2019 10.1007/s00277-019-03791-y 2019
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma
Yi1, JH; Lee, GW; Do, YR; Jung, HR; Hong, JY; Yoon, DH; Suh, C; Choi, YS; Yi, SY; Sohn, BS; Kim, BS; Oh, SY; Park, J; Jo, JC; Lee, SS; Oh, YH; Kim, SJ; Kim, WS
View PubMed
-
MEDICINE 2019 10.1097/MD.0000000000017641 2019
Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997-2016 An observational study
Sim1, J; Takayama, T; Cho, J; Kim, SJ; Kim, WS; Ree, HJ; Ko, YH
View PubMed
-
BMC CANCER 2019 10.1186/s12885-019-6303-z 2019
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma
Kim1, SJ; Yoon, DH; Kang, HJ; Hong, JY; Lee, HS; Oh, SY; Shin, HJ; Kong, JH; Yi, JH; Sakamoto, K; Ko, YH; Huh, J; Lee, SS; Takeuchi, K; Shin, DY; Suh, C; Kim, WS
View PubMed
-
SCI REP-UK 2019 10.1038/s41598-019-51522-0 2019
A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study
Tan1, KM; Chia, B; Lim, JQ; Khoo, LP; Cheng, CL; Tan, L; Poon, E; Somasundaram, N; Farid, M; Tang, TPL; Tao, M; Cheah, DMZ; Laurensia, Y; Pang, JWL; Song, T; Tan, J; Huang, DC; Kim, SJ; Kim, WS; Ong, CK; Lim, ST; Chan, JY
View PubMed
-
J CLIN APHERESIS 2019 10.1002/jca.21734 2019
Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma
Park1, Y; Kim, DS; Jeon, MJ; Lee, BH; Yu, ES; Kang, KW; Lee, SR; Sung, HJ; Nam, MH; Yoon, SY; Choi, CW; Kang, ES; Cho, D; Kim, K; Kim, BS; Kim, DW; Kim, SJ
View PubMed
-
INT J HEMATOL 2019 10.1007/s12185-019-02693-z 2019
The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores
Huh1, S; Oh, SY; Lee, S; Lee, JH; Kim, SH; Lee, GW; Kim, SJ; Kim, WS; Lee, HS; Jo, JC; Kim, MJ; Kwon, JH; Kim, HJ
View PubMed
-
CANCER RES TREAT 2019 10.4143/crt.2018.555 2019
Body Cavity- Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma
Shin1, J; Ko, YH; Oh, SY; Yoon, DH; Lee, JO; Kim, JS; Park, Y; Shin, HJ; Kim, SJ; Won, JH; Yoon, SS; Kim, WS; Koh, Y
View PubMed
-
ANN LAB MED 2019 10.3343/alm.2019.39.5.430 2019
Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis
Park1, MS; Yoo, IY; Kim, HJ; Kim, SH; Kim, SJ; Cho, D
View PubMed
-
Cancer Med 2019 10.1002/cam4.2347 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma
Li Chan1, EH; Koh, LP; Lee, J; De Mel, S; Jeyasekharan, A; Liu, X; Tang, T; Lim, ST; Tao, M; Quek, R; Ras, MFB; Lee, YS; Diong, C; Tan, D; Kim, SJ; Chee, YL; Poon, LM
View PubMed
-
SCI REP-UK 2019 10.1038/s41598-019-48513-6 2019
Prognostic values of novel biomarkers in patients with AL amyloidosis
Kim1, D; Lee, G; Choi, JO; Kim, K; Kim, S; Ju, ES; Jeon, ES
View PubMed
-
BIOL BLOOD MARROW TR 2019 10.1016/j.bbmt.2019.03.016 2019
A Phase I/II Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study
Park1, SS; Kim, K; Kim, SJ; Lee, JH; Yoon, SS; Mun, YC; Lee, JJ; Eom, HS; Kim, JS; Min, CK
View PubMed
-
LEUKEMIA LYMPHOMA 2019 10.1080/10428194.2019.1573998 2019
Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes
Shin1, SH; Kim, YJ; Lee, D; Cho, D; Ko, YH; Cho, J; Park, WY; Park, D; Kim, SJ; Kim, WS
View PubMed
-
SCI REP-UK 2019 10.1038/s41598-019-44245-9 2019
Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
Kim1, D; Lee, GY; Choi, JO; Kim, K; Kim, SJ; Jeon, ES
View PubMed
-
CANCER RES TREAT 2019 10.4143/crt.2018.191 2019
Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus-Positive and -Negative Relapsed or Refractory Non-Hodgkin Lymphomas
Kim1, SJ; Hyeon, J; Cho, I; Ko, YH; Kim, WS
View PubMed
-
CANCER RES TREAT 2019 10.4143/crt.2018.190 2019
Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma
Lee1, H; Oh, D; Yang, K; Ko, YH; Ahn, YC; Kim, WS; Kim, SJ
View PubMed
-
BONE MARROW TRANSPL 2019 10.1038/s41409-018-0253-y 2019
A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing <= 70 kg
Kuruvilla1, J; Tzeng, CH; Cho, SG; Kim, SJ; Tang, JL; Su, YM; Wu, JY; Vargo, R; Cheverton, P
View PubMed
-
ANN HEMATOL 2019 10.1007/s00277-018-3516-1 2019
Validation of the Marginal Zone Lymphoma International Prognostic Index
Hong1, J; Cho, J; Ko, YH; Kim, SJ; Kim, WS
View PubMed
-
CYTOKINE 2019 10.1016/j.cyto.2018.10.009 2019
Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma
Yi1, JH; Ryu, KJ; Ko, YH; Kim, WS; Kim, SJ
View PubMed
-
LEUKEMIA LYMPHOMA 2019 10.1080/10428194.2018.1480772 2019
Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphoma
Lim1, SW; Ryu, KJ; Lee, H; Ko, YH; Kim, WS; Kim, SJ
View PubMed
-
EUR J NUCL MED MOL I 2018 10.1007/s00259-018-4093-1 2018
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
Yhim1, HY; Park, Y; Han, YH; Kim, S; Kang, SR; Moon, JH; Jeong, JH; Shin, HJ; Kim, K; Choi, YS; Kim, K; Kim, MK; Kong, E; Kim, DS; Eo, JS; Lee, JH; Kang, DY; Lee, WS; Lee, SM; Do, YR; Ham, JS; Kim, SJ; Kim, WS; Choi, JY; Yang, DH; Kwak, JY
View PubMed
-
CANCER SCI 2018 10.1111/cas.13844 2018
Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma
Kim1, SJ; Shu, C; Ryu, KJ; Kang, D; Cho, J; Ko, YH; Lee, SY; Guallar, E; Zhao, W; Kim, WS
View PubMed
-
BIOL BLOOD MARROW TR 2018 10.1016/j.bbmt.2018.07.034 2018
Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation
Jeong1, SH; Song, HN; Park, JS; Yang, DH; Koh, Y; Yoon, SS; Lee, HW; Eom, HS; Won, JH; Kim, WS; Kim, SJ
View PubMed
-
ANN HEMATOL 2018 10.1007/s00277-018-3442-2 2018
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms
Hwang1, HS; Yoon, DH; Hong, JY; Park, CS; Lee, YS; Ko, YH; Kim, SJ; Kim, WS; Suh, C; Huh, J
View PubMed
-
J CLIN MICROBIOL 2018 10.1128/JCM.00438-18 2018
Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients
Ryu1, MR; Park, MS; Cho, EH; Jung, CW; Kim, K; Kim, SJ; Oh, HY; Huh, W; Jang, HR; Koh, WJ; Park, HY; Kim, YH; Sinn, DH; Choi, JO; Joh, JW; Kim, JM; Kim, SJ; Park, JB; Kang, ES
View PubMed
-
CANCER RES TREAT 2018 10.4143/crt.2017.207 2018
Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study
Kang1, D; Cho, J; Kim, IR; Kim, MK; Kim, WS; Kim, SJ
View PubMed
-
ANN HEMATOL 2018 10.1007/s00277-018-3387-5 2018
Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study
Oh1, SY; Kim, WS; Kang, HJ; Lee, JH; Huh, S; Kim, S; Yoon, DH; Hong, JY; Lee, WS; Kim, HJ; Won, JH; Park, BB; Lee, SI; Suh, C
View PubMed
-
INVEST NEW DRUG 2018 10.1007/s10637-018-0582-0 2018
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy
Cho1, H; Yoon, DH; Kim, KP; Bae, KS; Kim, WS; Eom, HS; Kim, JS; Hong, JY; Kim, SJ; Lee, H; Kim, SJ; Suh, C
View PubMed
-
MODERN PATHOL 2018 10.1038/s41379-018-0064-0 2018
Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement
Hyeon1, J; Lee, B; Shin, SH; Yoo, HY; Kim, SJ; Kim, WS; Park, WY; Ko, YH
View PubMed
-
ANN HEMATOL 2018 10.1007/s00277-018-3313-x 2018
Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma
Cho1, J; Kim, SJ; Park, S; Yoo, KH; Ki, CS; Ko, Y; Kim, WS
View PubMed
-
ANN HEMATOL 2018 10.1007/s00277-018-3317-6 2018
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
Hong1, JY; Yoon, DH; Suh, C; Kim, WS; Kim, SJ; Jo, JC; Kim, JS; Lee, WS; Oh, SY; Park, Y; Kim, SY; Lee, MH; Lee, HS; Do, YR
View PubMed
-
GENOME RES 2018 10.1101/gr.228080.117 2018
Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data
Fan1, J; Lee, HO; Lee, S; Ryu, DE; Lee, S; Xue, C; Kim, SJ; Kim, K; Barkas, N; Park, PJ; Park, WY; Kharchenko, PV
View PubMed
-
BONE MARROW TRANSPL 2018 10.1038/s41409-018-0097-5 2018
Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study
Yoo1, KH; Kang, D; Kim, IR; Choi, EK; Kim, JS; Yoon, SS; Lee, CH; Park, S; Kim, SJ; Kim, K; Kim, WS; Jung, CW; Choi, HJ; Jang, JH; Cho, J
View PubMed
-
ANTICANCER RES 2018 10.21873/anticanres.12679 2018
The Potential of Exosomes Derived from Chronic Myelogenous Leukaemia Cells as a Biomarker
Kang1, KW; Jung, JH; Hur, W; Park, J; Shin, H; Choi, B; Jeong, H; Kim, DS; Yu, ES; Lee, SR; Sung, HJ; Kim, SJ; Choi, CW; Kim, HK; Hong, S; Park, JH; Choi, Y; Park, Y; Kim, BS
View PubMed
-
BRIT J HAEMATOL 2018 10.1111/bjh.14701 2018
A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System
Jung1, SH; Kim, K; Kim, JS; Kim, SJ; Cheong, JW; Kim, SJ; Ahn, JS; Ahn, SY; Yang, DH; Kim, HJ; Lee, JJ
View PubMed
-
CANCER SCI 2018 10.1111/cas.13597 2018
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy
Yamaguchi1, M; Suzuki, R; Kim, SJ; Ko, YH; Oguchi, M; Asano, N; Miyazaki, K; Terui, Y; Kubota, N; Maeda, T; Kobayashi, Y; Amaki, J; Soejima, T; Saito, B; Shimoda, E; Fukuhara, N; Tsukamoto, N; Shimada, K; Choi, I; Utsumi, T; Ejima, Y; Kim, WS; Katayama, N
View PubMed
-
CANCER RES TREAT 2018 10.4143/crt.2017.182 2018
Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell
Lee1, GI; Oh, D; Kim, WS; Kim, SJ; Ko, YH; Woo, KI; Kim, YD; Ahn, YC
View PubMed
-
HUM PATHOL 2018 10.1016/j.humpath.2017.12.006 2018
Identification of T-cell receptor expression in EBV-positive neoplastic cells in extranodal NK/T-cell lymphoma, nasal-type, and comparison with T-cell receptor gene rearrangement by BIOMED-2 assay
Takayama1, T; Shin, S; Kang, S; Kim, SJ; Kim, WS; Ko, YH
View PubMed
-
PLoS One 2018 10.1371/journal.pone.0192656 2018
Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
Kang1, KW; Lee, SR; Kim, DS; Yu, ES; Sung, HJ; Kim, SJ; Choi, CW; Park, Y; Kim, BS
View PubMed
-
Blood Cancer J 2018 10.1038/s41408-018-0056-9 2018
CXCR4 can induce PI3K delta inhibitor resistance in ABC DLBCL
Kim1, JH; Kim, WS; Ryu, KJ; Kim, SJ; Park, C
View PubMed
-
ANN ONCOL 2018 10.1093/annonc/mdx684 2018
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/IINK/T-cell lymphoma
Kwong1, YL; Kim, SJ; Tse, E; Oh, SY; Kwak, JY; Eom, HS; Do, YR; Mun, YC; Lee, SR; Shin, HJ; Suh, C; Chuang, SS; Lee, YS; Lim, ST; Izutsu, K; Suzuki, R; Relander, T; d'Amore, F; Schmitz, N; Jaccard, A; Kim, WS
View PubMed
-
CANCER RES TREAT 2018 10.4143/crt.2017.091 2018
Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors
Cho1, J; Kang, D; Kim, IR; Kim, WS; Ferrell, B; Kim, SJ
View PubMed
-
HEMATOL ONCOL 2017 10.1002/hon.2374 2017
Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma
Hong1, JY; Ryu, KJ; Lee, JY; Park, C; Ko, YH; Kim, WS; Kim, SJ
View PubMed
-
Blood Cancer J 2017 10.1038/s41408-017-0030-y 2017
Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers
Tang1, T; Khoo, LP; Lim, C; Ham, JS; Kim, SJ; Hong, HM; Phipps, C; Lee, YS; Tao, M; Quek, R; Farid, M; Lin, TY; Kim, WS; Lim, ST
View PubMed
-
HEMATOL ONCOL 2017 10.1002/hon.2374 2017
Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma
Hong1, JY; Ryu, KJ; Lee, JY; Park, C; Ko, YH; Kim, WS; Kim, SJ
View PubMed
-
JPN J CLIN ONCOL 2017 10.1093/jjco/hyx120 2017
Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy
Park1, JS; Lim, DH; Ahn, YC; Park, W; Kim, SJ; Kim, WS; Kim, K
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.20988 2017
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
Hong1, J; Kim, SJ; Chang, MH; Kim, JA; Kwak, JY; Kim, JS; Yoon, DH; Lee, WS; Do, YR; Kang, HJ; Eom, HS; Park, Y; Won, JH; Mun, YC; Kim, HJ; Kwon, JH; Kong, JH; Oh, SY; Lee, S; Bae, SH; Yang, DH; Jun, HJ; Lee, HS; Yun, HJ; Lee, SI; Kim, MK; Yi, JH; Lee, JH; Kim, WS; Suh, C
View PubMed
-
LANCET INFECT DIS 2017 2017
Mycobacterium abscessus glossitis
Ko1, JH; Kang, CI; Cho, SY; Ha, YE; Lee, NY; Kim, SJ; Chung, DR; Peck, KR; Song, JH
View PubMed
-
ANN ONCOL 2017 10.1093/annonc/mdx316 2017
Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease
Lim1, SH; Hong, JY; Lim, ST; Hong, H; Arnoud, J; Zhao, W; Yoon, DH; Tang, T; Cho, J; Park, S; Ko, YH; Kim, SJ; Suh, C; Lin, T; Kim, WS
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.19301 2017
Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma
Ham1, JS; Park, HY; Ryu, KJ; Ko, YH; Kim, WS; Kim, SJ
View PubMed
-
KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2015.406 2017
Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea
Kim1, HS; Kim, HJ; Kim, SH; Choi, JY; Ko, YH; Kim, WS; Jung, CW; Kim, SJ
View PubMed
-
HEMATOL ONCOL 2017 10.1002/hon.2283 2017
Macrophage inflammatory protein 1 alpha (MIP-1) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma
Kim1, HS; Ryu, KJ; Ko, YH; Kim, HJ; Kim, SH; Kim, WS; Kim, SJ
View PubMed
-
Leuk Lymphoma. 2017 Jun;58(6):1341-1348. doi: 10.1080/10428194.2016.1236380. Epub 2016 Oct 9. 2017
Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma
Moon SH11, Lee AY1, Kim WS2, Kim SJ2, Cho YS1, Choe YS1, Kim BT1, Lee KH1.
View PubMed
-
Ann Hematol. 2017 May;96(5):739-747. doi: 10.1007/s00277-017-2940-y. Epub 2017 Feb 9. 2017
Sexual problems in male vs. female non-Hodgkin lymphoma survivors: prevalence, correlates, and associations with health-related quality of life
Kim IR11, Kim SH2, Ok ON3, Kim SH4, Lee S5, Choi E6, Kim SJ7, Yoon DH8, Lee MH9.
View PubMed
-
Nutrition. 2017 Apr;36:67-71. doi: 10.1016/j.nut.2016.06.009. Epub 2016 Jun 25. 2017
Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma
Kim HS11, Lee JY2, Lim SH2, Cho J3, Kim SJ2, Jang JH2, Kim WS2, Jung CW2, Kim K4.
View PubMed
-
Blood. 2017 Apr 27;129(17):2437-2442. doi: 10.1182/blood-2016-12-756841. Epub 2017 Feb 10. 2017
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase
Kwong YL11, Chan TSY1, Tan D2,3, Kim SJ4, Poon LM5, Mow B6, Khong PL7, Loong F8, Au-Yeung R8, Iqbal J9, Phipps C2,3, Tse E1.
View PubMed
-
Oncotarget. 2017 Mar 7;8(10):17038-17049. doi: 10.18632/oncotarget.14928. 2017
The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP
Jung H11,2, Yoo HY3, Lee SH3, Shin S4, Kim SC1, Lee S1, Joung JG1, Nam JY1,3, Ryu D1,3, Yun JW1,5, Choi JK2, Ghosh A5, Kim KK5, Kim SJ6, Kim WS6, Park WY1, Ko YH4.
View PubMed
-
Oncotarget. 2017 Mar 28;8(13):22014-22022. doi: 10.18632/oncotarget.15782. 2017
Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm
Yoon N11, Ahn S2, Yong Yoo H3, Jin Kim S4, Seog Kim W4, Hyeh Ko Y5.
View PubMed
-
Psychooncology. 2017 Mar;26(3):330-336. doi: 10.1002/pon.4136. Epub 2016 Apr 13. 2017
Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life
Kim SH11, Lee S2, Kim SH3, Ok ON4, Kim IR5, Choi E1, Kang YK6, Kim SJ7, Lee MH8.
View PubMed
-
Bone Marrow Transplant. 2017 Feb;52(2):258-263. doi: 10.1038/bmt.2016.260. Epub 2016 Nov 7. 2017
Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation
Lee MH11, Jang JH2, Min HJ3, Jang HI2, Nah JH2, Lyu CJ4, Han KS5, Won JH6, Lee YH7, Chong SY8, Mun YC9, Lee WS10, Kim SJ11, Kim I12.
View PubMed
-
Oncotarget. 2017 Feb 21;8(8):13782-13791. doi: 10.18632/oncotarget.14636. 2017
Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Hong JY11, Ryu KJ2, Park C3, Hong M4, Ko YH5, Kim WS6, Kim SJ2,6.
View PubMed
-
ONCOTARGET, JAN 17 2017, 8(3):5361-5370, DOI: 10.18632/oncotarget.14243 2017
Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-kappa B and Btk
Kim JH1, Kim WS, Hong JY, Ryu KJ, Kim SJ, Park C
View PubMed
-
Oncotarget. 2017 Jan 10;8(2):2466-2476. doi: 10.18632/oncotarget.13690. 2017
FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma
Ryu KJ11, Park C2, Hong M3, Ko YH4, Kim WS5, Kim SJ1,5.
View PubMed
-
Cancer Res Treat. 2017 Jan;49(1):92-103. doi: 10.4143/crt.2015.476. Epub 2016 May 9. 2017
Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma
Maeng CH11, Ko YH2, Lim DH3, Kang ES4, Choi JY5, Kim WS6, Kim SJ6,7.
View PubMed
-
Mod Pathol. 2017 Jan;30(1):4-14. doi: 10.1038/modpathol.2016.56. Epub 2016 Sep 30. 2017
Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression
Son SM11, Ha SY1, Yoo HY2,3, Oh D4, Kim SJ3,5, Kim WS3,5, Ko YH1,3.
View PubMed
-
Oncotarget. 2016 Dec 27;7(52):86433-86445. doi: 10.18632/oncotarget.13239. 2016
Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma
Park HY11,2, Lee SB3, Yoo HY4, Kim SJ5, Kim WS5, Kim JI1, Ko YH2.
View PubMed
-
Oncotarget. 2016 Dec 20;7(51):85584-85591. doi: 10.18632/oncotarget.11319. 2016
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL1008)
Yoon DH11, Kim SJ2, Jeong SH3, Shin DY4, Bae SH5, Hong J6, Park SK7, Yhim HY8, Yang DH9, Lee H10, Kang HJ11, Lee MH12, Eom HS10, Kwak JY8, Lee JH6, Suh C1, Kim WS2.
View PubMed
-
Oncotarget. 2016 Nov 22;7(47):76934-76943. doi: 10.18632/oncotarget.12734. 2016
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
Seo S11, Hong JY1, Yoon S1,2, Yoo C1, Park JH1, Lee JB3, Park CS4, Huh J5, Lee Y5, Kim KW6, Ryu JS7, Kim SJ8, Kim WS8, Yoon DH1, Suh C1.
View PubMed
-
Ann Oncol. 2016 Nov;27(11):2133-2134. Epub 2016 Aug 8. 2016
Reply to the letter to the editor 'Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin, histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma' by Tan et al.
Kim SJ11,2, Kim WS3.
View PubMed
-
J Infect. 2016 Nov;73(5):496-505. doi: 10.1016/j.jinf.2016.06.011. Epub 2016 Jul 7. 2016
Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients
Park S11, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Chung DR2, Kang CI2, Peck KR2, Jung CW3.
View PubMed
-
Int J Hematol. 2016 Nov;104(5):591-595. Epub 2016 Jul 25. 2016
Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma
Jung KS11,2, Cho SH2, Kim SJ1, Ko YH3, Kim WS4.
View PubMed
-
Oncotarget. 2016 Nov 1;7(44):72033-72043. doi: 10.18632/oncotarget.12459. 2016
Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study
Kim SJ11, Hong JS2, Chang MH3, Kim JA4, Kwak JY5, Kim JS6, Yoon DH7, Lee WS8, Do YR9, Kang HJ10, Eom HS11, Park Y12, Won JH13, Mun YC14, Kim HJ15, Kwon JH16, Kong JH17, Oh SY18, Lee S19, Bae SH20, Yang DH21, Jun HJ22, Kim YS23, Yun HJ24, Lee SI25, Kim MK26, Park EK27, Kim WS1, Suh C7.
View PubMed
-
Oncotarget. 2016 Oct 18;7(42):68350-68359. doi: 10.18632/oncotarget.12029. 2016
Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis
Kim SJ11, Shin HT2, Lee HO2, Kim NK2, Yun JW2, Hwang JH3, Kim K1, Park WY2.
View PubMed
-
Acta Haematol. 2016;136(3):186-90. doi: 10.1159/000448159. Epub 2016 Sep 14. 2016
Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma
Song HN11, Kim SJ, Ko YH, Kim WS.
View PubMed
-
Oncotarget. 2016 Sep 13;7(37):59892-59901. doi: 10.18632/oncotarget.10988. 2016
Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation
Park S11, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Jung CW1.
View PubMed
-
BMC Cancer. 2016 Aug 8;16:613. doi: 10.1186/s12885-016-2645-y. 2016
Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
Jung SH11, Cho MS1, Kim HK2, Kim SJ2, Kim K3, Cheong JW4, Kim SJ4, Kim JS4, Ahn JS1, Kim YK1, Yang DH1, Kim HJ1, Lee JJ5; Korean Multiple Myeloma Working Party (KMMWP).
View PubMed
-
Oncotarget. 2016 Jul 26;7(30):47127-47133. doi: 10.18632/oncotarget.9478. 2016
Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker
Ryu D11,2, Kim HJ3, Joung JG1, Lee HO1,4, Bae JS1, Kim SJ5, Kim H5, Park WY1,2,4, Kim K5.
View PubMed
-
Leuk Lymphoma. 2016;57(6):1413-22. doi: 10.3109/10428194.2015.1113276. Epub 2015 Dec 24. 2016
CD79B limits response of diffuse large B cell lymphoma to ibrutinib
Kim JH11, Kim WS1,2, Ryu K1, Kim SJ1,2, Park C1.
View PubMed
-
Bone Marrow Transplant. 2016 Jun;51(6):807-12. doi: 10.1038/bmt.2016.6. Epub 2016 Feb 8. 2016
Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL
Lim SH11, Hyun SH2, Kim HS1, Lee JY1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Park S1, Ko YH3, Kim SJ1, Choi JY2, Kim WS1.
View PubMed
-
Haematologica. 2016 Jun;101(6):e271. doi: 10.3324/haematol.2016.148015. Epub 2016 May 31. 2016
Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
Yoo HY11, Kim P2, Kim WS3, Lee SH1, Kim S4, Kang SY5, Jang HY6, Lee JE6, Kim J7, Kim SJ3, Ko YH8, Lee S9.
View PubMed
-
Haematologica. 2016 Jun;101(6):757-63. doi: 10.3324/haematol.2015.139253. Epub 2016 Jan 27. 2016
Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma
Yoo HY11, Kim P2, Kim WS3, Lee SH4, Kim S5, Kang SY6, Jang HY7, Lee JE7, Kim J8, Kim SJ3, Ko YH9, Lee S10.
View PubMed
-
Ann Lab Med. 2016 May;36(3):209-14. doi: 10.3343/alm.2016.36.3.209. 2016
Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma
Shin SY11,2, Lee ST2,3, Kim HJ2, Oh YL4, Kim SJ5, Kim WS5, Kim SH6.
View PubMed
-
Korean J Intern Med. 2016 May;31(3):560-9. doi: 10.3904/kjim.2014.222. Epub 2016 Feb 22. 2016
Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy
Maeng CH11,2, Ahn SW3, Ryu SY3, Han S3, Ko YH4, Ji JH5, Kim WS2, Kim SJ2.
View PubMed
-
Ann Hematol. 2016 May;95(6):911-9. doi: 10.1007/s00277-016-2660-8. Epub 2016 Apr 6. 2016
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
Lee HS11, Min CK2, Lee JJ3, Kim K4, Kim SJ4, Yoon DH5, Eom HS6, Lee H6, Lee WS7, Shin HJ8, Lee JH9, Park Y10, Jo JC11, Do YR12, Mun YC13, Lee MH14
View PubMed
-
Mod Pathol. 2016 May;29(5):430-43. doi: 10.1038/modpathol.2016.47. Epub 2016 Mar 25. 2016
Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior
Hong M11,2, Lee T1, Young Kang S1, Kim SJ3, Kim W3, Ko YH1.
View PubMed
-
Cancer Chemother Pharmacol. 2016 Apr;77(4):865-73. doi: 10.1007/s00280-016-3005-y. Epub 2016 Mar 16. 2016
Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis
Shin DY11, Kim SJ2, Yoon DH3, Park Y4, Kong JH5, Kim JA6, Kim BS7, Kim HJ8, Won JH9, Park SK10, Kim WS11.
View PubMed
-
Ann Oncol. 2016 Apr;27(4):712-8. doi: 10.1093/annonc/mdv624. Epub 2016 Feb 8. 2016
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas
Kim SJ11, Shin DY2, Kim JS3, Yoon DH4, Lee WS5, Lee H6, Do YR7, Kang HJ2, Eom HS6, Ko YH8, Lee SH9, Yoo HY10, Hong M11, Suh C4, Kim WS12.
View PubMed
-
J Hematol Oncol. 2016 Apr 18;9:41. doi: 10.1186/s13045-016-0271-4. 2016
L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia
Jung KS11,2, Cho SH2, Kim SJ1, Ko YH3, Kang ES4, Kim WS5.
View PubMed
-
Lancet Oncol. 2016 Mar;17(3):389-400. doi: 10.1016/S1470-2045(15)00533-1. Epub 2016 Feb 10. 2016
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Kim SJ11, Yoon DH2, Jaccard A3, Chng WJ4, Lim ST5, Hong H6, Park Y7, Chang KM8, Maeda Y9, Ishida F10, Shin DY11, Kim JS12, Jeong SH13, Yang DH14, Jo JC15, Lee GW16, Choi CW17, Lee WS18, Chen TY19, Kim K20, Jung SH20, Murayama T21, Oki Y22, Advani R23, d'Amore F24, Schmitz N25, Suh C2, Suzuki R26, Kwong YL27, Lin TY6, Kim WS28.
View PubMed
-
Ann Hematol. 2016 Mar;95(4):581-91. doi: 10.1007/s00277-015-2581-y. Epub 2016 Jan 4. 2016
Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability
Kim SM11, Park S1, Oh DR2, Ahn YC2, Ko YH3, Kim SJ1, Kim WS4.
View PubMed
-
Ann Oncol. 2016 Mar;27(3):508-13. doi: 10.1093/annonc/mdv596. Epub 2015 Dec 9. 2016
Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin
Kim SJ11, Kim JH2, Ki CS3, Ko YH4, Kim JS5, Kim WS6.
View PubMed
-
Oncotarget. 2016 Mar 15;7(11):12359-71. doi: 10.18632/oncotarget.7132. 2016
Clonal relationships in recurrent B-cell lymphomas
Lee SE11, Kang SY2, Yoo HY3, Kim SJ4, Kim WS4, Ko YH2.
View PubMed
-
Blood Cancer J. 2016 Feb 12;6:e395. doi: 10.1038/bcj.2016.2. 2016
The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma
Ham JS11, Kim SJ1, Choi JY2, Hyun SH2, Choi SK3, Kim HS1, Lim SH1, Lee JY1, Jung SH3, Ko YH4, Kim WS1.
View PubMed
-
Cancer Res Treat. 2016 Jan;48(1):312-21. doi: 10.4143/crt.2014.266. Epub 2015 Mar 2. 2016
Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism
Lim SH11, Woo SY2, Kim S2, Ko YH3, Kim WS1, Kim SJ1.
View PubMed
-
Ann Hematol. 2016 Jan;95(2):325-35. doi: 10.1007/s00277-015-2523-8. Epub 2015 Oct 10. 2016
Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis
Lim SH11, Park S1, Jang JH1, Kim K1, Kim HJ2, Kim SH2, Kang CI3, Chung DR3, Peck KR3, Lee J4, Cha HS4, Koh EM4, Ko YH5, Kim WS1, Jung CW1, Kim SJ6,7.
View PubMed
-
Int J Hematol. 2015 Dec;102(6):678-88. 2015
Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large B-cell lymphoma with secondary central nervous system involvement
Lee MY1, Kim HS, Lee JY, Lim SH, Kang ES, Ko YH, Kim SJ, Kim WS.
View PubMed
-
Oncotarget. 2015 Dec 15;6(40):42803-12. doi: 10.18632/oncotarget.5658. 2015
Iron deficient erythropoiesis might play key role in development of anemia in cancer patients
Park S11, Jung CW1, Kim K1, Kim SJ1, Kim WS1, Jang JH1.
View PubMed
-
J Clin Lab Anal. 2015 Nov;29(6):505-10. doi: 10.1002/jcla.21801. Epub 2014 Oct 2. 2015
Antigen Expression Patterns of Plasma Cell Myeloma: An Association of Cytogenetic Abnormality and International Staging System (ISS) for Myeloma
Shin SY11, Lee ST1, Kim HJ1, Kim SJ2, Kim K2, Kang ES1, Kim SH1.
View PubMed
-
Leuk Lymphoma. 2015;56(11):3052-7. doi: 10.3109/10428194.2015.1025391. Epub 2015 Apr 8. 2015
A subset of CD45+/CD19-cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma
Kim SM11, Lee ST2,3, Ryu KJ4, Kim HJ2, Kim SH2, Ko YH5, Kim WS1, Kim SJ1,6.
View PubMed
-
Haematologica. 2015 Dec;100(12):e505-7. doi: 10.3324/haematol.2015.133074. Epub 2015 Sep 24. 2015
A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients
Lee SH11, Kim JS1, Kim J2, Kim SJ3, Kim WS3, Lee S2, Ko YH4, Yoo HY5.
View PubMed
-
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):677-83. doi: 10.1016/j.ijrobp.2015.07.2267. Epub 2015 Jul 22. 2015
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Oh D11, Ahn YC2, Kim SJ3, Kim WS3, Ko YH4.
View PubMed
-
Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12. 2015
Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy
Lee JY11, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.
View PubMed
-
Transpl Infect Dis. 2015 Oct;17(5):679-87. doi: 10.1111/tid.12424. Epub 2015 Sep 26. 2015
Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma
Park S11, Jung CW1, Jang JH1, Kim SJ1, Kim WS1, Kim K1.
View PubMed
-
Int J Hematol. 2015 Oct;102(4):420-5. doi: 10.1007/s12185-015-1845-6. Epub 2015 Jul 26. 2015
Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma: Consortium for Improving Survival of Lymphoma (CISL) study
Koh MS11, Kim WS2, Kim SJ2, Oh SY3, Yoon DH4, Lee SI5, Hong J6, Song MK7, Shin HJ7, Kwon JH8, Kim HJ8, Do YR9, Suh C10, Kim HJ1.
View PubMed
-
Int Forum Allergy Rhinol. 2015 Oct;5(10):960-6. doi: 10.1002/alr.21564. Epub 2015 Jun 3. 2015
Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type
Cho HJ11, Jang MS2, Hong SD2, Kim SJ3, Ahn YC4, Oh D4, Ko YH5, Kim HY2, Dhong HJ2, Chung SK2, Kim WS3.
View PubMed
-
Hum Immunol. 2015 Sep;76(9):636-43. doi: 10.1016/j.humimm.2015.09.009. Epub 2015 Sep 25. 2015
KIR alloreactivity based on the receptor-ligand model is associated with improved clinical outcomes of allogeneic hematopoietic stem cell transplantation: Result of single center prospective study
Park S11, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Kang ES2, Jung CW3.
View PubMed
-
Curr Opin Oncol. 2015 Sep;27(5):392-8. doi: 10.1097/CCO.0000000000000210. 2015
Epstein - Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update
Hong JY11, Ko YH, Kim SJ, Kim WS.
View PubMed
-
Biol Blood Marrow Transplant. 2015 Sep;21(9):1597-604. doi: 10.1016/j.bbmt.2015.05.003. Epub 2015 May 8. 2015
Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma
Yhim HY11, Kim JS2, Mun YC3, Moon JH4, Chae YS4, Park Y5, Jo JC6, Kim SJ7, Yoon DH8, Cheong JW2, Kwak JY1, Lee JJ9, Kim WS7, Suh C8, Yang DH10; Consortium for Improving Survival of Lymphoma Study.
View PubMed
-
Ann Hematol. 2015 Sep;94(9):1485-92. doi: 10.1007/s00277-015-2389-9. Epub 2015 May 6. 2015
Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
Kim DS11, Kang KW, Lee SR, Park Y, Sung HJ, Kim SJ, Choi CW, Kim BS.
View PubMed
-
Oncotarget. 2015 Jul 10;6(19):17764-76. 2015
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
Lee S11, Park HY2, Kang SY3, Kim SJ4, Hwang J2, Lee S5, Kwak SH6, Park KS6,7, Yoo HY5, Kim WS4, Kim JI1,2,8, Ko YH3.
View PubMed
-
Korean J Intern Med. 2015 Jul;30(4):496-505. doi: 10.3904/kjim.2015.30.4.496. Epub 2015 Jun 29. 2015
Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience
Lim AY11, Lee JH1, Jung KS1, Gwag HB1, Kim do H1, Kim SJ1, Lee GY1, Kim JS2, Kim HJ3, Lee SY3, Lee JE1, Jeon ES1, Kim K1.
View PubMed
-
Cancer Res Treat. 2015 Jul;47(3):448-57. doi: 10.4143/crt.2014.034. Epub 2014 Nov 3. 2015
Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis
Park S11, Kang CI2, Chung DR2, Peck KR2, Kim WS1, Kim SJ1.
View PubMed
-
Anticancer Res. 2015 Jun;35(6):3333-40. 2015
Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma
Lim do H11, Kim WS2, Kim SJ3, Yoo HY4, Ko YH5.
View PubMed
-
Genes Chromosomes Cancer. 2015 Jun;54(6):383-96. doi: 10.1002/gcc.22249. Epub 2015 Mar 31. 2015
Integrated Copy Number and Gene Expression Profiling Analysis of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma
Yoon H11, Park S, Ju H, Ha SY, Sohn I, Jo J, Do IG, Min S, Kim SJ, Kim WS, Yoo HY, Ko YH.
View PubMed
-
J Hematol Oncol. 2015 May 14;8:49. doi: 10.1186/s13045-015-0142-4. 2015
The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
Kim SJ11,2, Ryu KJ3, Hong M4, Ko YH5, Kim WS6.
View PubMed
-
Ann Hematol. 2015 Apr;94(4):617-25. doi: 10.1007/s00277-014-2258-y. Epub 2014 Dec 3. 2015
Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation
Jeong SH11, Moon JH, Kim JS, Yang DH, Park Y, Cho SG, Kwak JY, Eom HS, Won JH, Hong JS, Oh SY, Lee HS, Kim SJ.
View PubMed
-
Cancer Res Treat. 2015 Apr;47(2):173-81. doi: 10.4143/crt.2014.055. Epub 2014 Oct 28. 2015
Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis
Hong J11, Kim SJ2, Ahn JS3, Song MK4, Kim YR5, Lee HS6, Yhim HY7, Yoon DH8, Kim MK9, Oh SY10, Park Y11, Mun YC12, Do YR13, Ryoo HM14, Lee JJ3, Lee JH1, Kim WS2, Suh C8.
View PubMed
-
Leuk Lymphoma. 2015 Apr;56(4):1020-6. doi: 10.3109/10428194.2014.946027. Epub 2014 Aug 20. 2015
Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma
Lee GW11, Go SI, Kim SH, Hong J, Kim YR, Oh S, Kim SY, Do YR, Lee H, Lee SI, Bae SH, Oh SY, Song MK, Lee WS, Lee B, Kim JS, Kim MK, Kang HJ, Ahn JS, Yhim HY, Kim HJ, Kim SJ, Kim WS, Suh C; Consortium for Improving Survival of Lymphoma (CISL) study group.
View PubMed
-
Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):227-35. doi: 10.1016/j.clml.2014.12.007. Epub 2014 Dec 12. 2015
The t(11;14)(q13;q32) Trans location as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma
Shin HJ11, Kim K2, Lee JJ3, Song MK1, Lee EY4, Park SH4, Kim SH5, Jang MA5, Kim SJ6, Chung JS1.
View PubMed
-
Anticancer Res. 2015 Apr;35(4):2465-74. 2015
The Clinical Significance of Activated p-AKT Expression in Peripheral T-cell Lymphoma
Hong JY11, Hong ME2, Choi MK3, Chang W4, Do IG5, Jo JS5, Jung SH6, Park S7, Kim SJ7, Ko YH2, Kim WS8.
View PubMed
-
Haematologica. 2015 Mar;100(3):e106-9. doi: 10.3324/haematol.2014.116087. Epub 2014 Dec 5. 2015
Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator
Kim SJ11, Hong M2, Do IG2, Lee SH3, Ryu KJ4, Yoo HY5, Hong JY6, Ko YH2, Kim WS7.
View PubMed
-
Ann Oncol. 2015 Mar;26(3):548-55. doi: 10.1093/annonc/mdu556. Epub 2014 Dec 4. 2015
EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity
Hong JY11, Yoon DH2, Suh C2, Huh J3, Do IG4, Sohn I4, Jo J4, Jung SH5, Hong ME6, Yoon H6, Ko YH6, Kim SJ7, Kim WS8.
View PubMed
-
Int J Hematol. 2015 Mar;101(3):273-8. doi: 10.1007/s12185-014-1728-2. Epub 2015 Jan 1. 2015
Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea
Kim MJ11, Hong ME, Maeng CH, Jung HA, Hong JY, Choi MK, Kim SJ, Ko YH, Kim WS.
View PubMed
-
Ann Hum Genet. 2015 Mar;79(2):99-107. doi: 10.1111/ahg.12101. Epub 2015 Jan 23. 2015
Asp58Ala is the Predominant Mutation of the TTR Gene in Korean Patients with Hereditary Transthyretin-Related Amyloidosis
Jang MA11, Lee GY, Kim K, Kim SJ, Kim JS, Lee SY, Kim HJ, Jeon ES.
View PubMed
-
Acta Haematol. 2015;133(2):179-82. doi: 10.1159/000362149. Epub 2014 Oct 11. 2015
Pilot Trial of Systemic Methotrexate plus R-CHOP Regimen with Intrathecal Methotrexate for Simultaneous Central Nervous System and Systemic Diffuse Large B Cell Lymphoma
Yoo KH11, Lee JY, Lim SH, Ko YH, Kim SJ, Kim WS.
View PubMed
-
Ann Hematol. 2015 Jan;94(1):71-8. doi: 10.1007/s00277-014-2171-4. Epub 2014 Aug 2. 2015
Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients
Kim SJ11, Park S, Kang ES, Choi JY, Lim do H, Ko YH, Kim WS.
View PubMed
-
Ann Lab Med. 2015 Jan;35(1):149-51. doi: 10.3343/alm.2015.35.1.149. Epub 2014 Dec 8. 2015
Simultaneous Occurrence of Angioimmunoblastic T-cell Lymphoma and Plasma Cell Leukemia
Jang MA11, Lee ST1, Kim HJ1, Kim S2, Kim SH1.
View PubMed
-
Amyloid. 2014 Dec;21(4):261-6. doi: 10.3109/13506129.2014.960560. Epub 2014 Sep 24. 2014
Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis
Lee JY11, Lim SH, Kim SJ, Lee GY, Lee JE, Choi JO, Kim JS, Kim HJ, Lee SY, Min JH, Jeon ES, Kim K.
View PubMed
-
Ann Hematol. 2014 Nov;93(11):1895-901. doi: 10.1007/s00277-014-2137-6. Epub 2014 Jun 20. 2014
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
Kim SJ11, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, Won JH, Lee JH, Yoon DH, Cho J, Nam TK, Lee SW, Ahn YC, Suh C, Kim WS.
View PubMed
-
Vox Sang. 2014 Nov;107(4):407-15. doi: 10.1111/vox.12183. Epub 2014 Jul 31. 2014
Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience
Lee KH11, Jung SK, Kim SJ, Jang JH, Kim K, Kim WS, Jung CW, Kim DW, Kang ES.
View PubMed
-
Eur J Haematol. 2014 Nov;93(5):414-21. doi: 10.1111/ejh.12377. Epub 2014 Jun 14. 2014
Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma
Shin HJ11, Kim K, Lee JW, Song MK, Lee JJ, Lee HS, Lee WS, Kim SJ, Chung JS.
View PubMed
-
Leuk Lymphoma. 2014 Oct;55(10):2395-7. doi: 10.3109/10428194.2014.880429. Epub 2014 Mar 7. 2014
Spinal cord compression in multiple myeloma: a single center experience
Jung HA11, Cho SH, Kim SJ, Jang JH, Kim WS, Jung CW, Kim K.
View PubMed
-
Support Care Cancer. 2014 Oct;22(10):2669-75. doi: 10.1007/s00520-014-2256-6. Epub 2014 Apr 26. 2014
Impact of dose modification on intravenous Bortezomib-induced peripheral neuropathy in multiple myeloma patients
Cho J11, Kang D, Lee JY, Kim K, Kim SJ.
View PubMed
-
Ann Hematol. 2014 Sep;93(9):1571-7. doi: 10.1007/s00277-014-2067-3. Epub 2014 Apr 12. 2014
Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study
Ahn SY11, Jung SH, Joo YD, Lee WS, Lee SM, Choi CW, Kim SJ, Kim K, Lee JJ; Korean Multiple Myeloma Working Party.
View PubMed
-
Onco Targets Ther. 2014 Sep 26;7:1717-22. doi: 10.2147/OTT.S67380. eCollection 2014. 2014
Brentuximab vedotin for relapsed or refractory CD30+Hodgkin lymphoma: a multicenter analysis from Asia
Yang QM11, Hong JY2, Ko YH3, Lin SY4, Au WY4, Choi MK5, Park S6, Kim SJ6, Kim WS6.
View PubMed
-
Leuk Lymphoma. 2014 Sep;55(9):2196-8. doi: 10.3109/10428194.2013.871279. Epub 2014 Feb 17. 2014
Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma
Chang WJ11, Ko YH, Kim SJ, Kim WS.
View PubMed
-
Anticancer Res. 2014 Aug;34(8):4299-306. 2014
Renal Insufficiency in Newly-diagnosed Multiple Myeloma: Analysis According to International Myeloma Working Group Consensus Statement
Park S11, Han B2, Kim K3, Kim SJ1, Jang JH1, Kim WS1, Jung CW1.
View PubMed
-
Acta Haematol. 2014;132(2):226-32. 2014
Thalidomide, Cyclophosphamide and Dexamethasone Induction Therapy: Feasibility for Myeloma Patients Destined for Autologous Stem Cell Transplantation
Chang WJ1, Kang ES, Lee ST, Kim SH, Kim DW, Kim SJ, Kim K.
View PubMed
-
Support Care Cancer. 2014 Aug;22(8):2039-48. doi: 10.1007/s00520-014-2174-7. Epub 2014 Mar 5. 2014
Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy
Yoon YK11, Kim MJ, Sohn JW, Kim HS, Choi YJ, Kim JS, Kim ST, Park KH, Kim SJ, Kim BS, Shin SW, Kim YH, Park Y.
View PubMed
-
Biomed Res Int. 2014;2014:437852. doi: 10.1155/2014/437852. Epub 2014 Jul 10. 2014
Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma
Kim SM11, Kim MJ1, Jung HA1, Kim K1, Kim SJ1, Jang JH1, Kim WS1, Jung CW1.
View PubMed
-
Cancer Res Treat. 2014 Jul;46(3):307-11. doi: 10.4143/crt.2014.46.3.307. Epub 2014 Jul 15. 2014
Unusual Manifestation of Intravascular Large B-Cell Lymphoma: Severe Hypercalcemia with Parathyroid Hormone-Related Protein
Ha JM11, Kim E, Lee WJ, Hwang JW, Yune S, Ko YH, Choi JY, Kim SJ, Kim WS.
View PubMed
-
Biomed Res Int. 2014;2014:245247. doi: 10.1155/2014/245247. Epub 2014 Jun 23. 2014
Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study
Eom KS11, Kim SJ2, Lee JJ3, Suh C4, Kim JS5, Yoon SS6, Kim BS7, Kang HJ8, Choi YJ9, Kim CS10, Kim YS11, Kwak JY12, Kim YJ1, Joo YD13, Mun YC14, Jo DY15, Park JS16, Park CY17, Kim SH18, Min CK1.
View PubMed
-
Mayo Clin Proc. 2014 Jun;89(6):781-9. doi: 10.1016/j.mayocp.2014.01.013. Epub 2014 Apr 3. 2014
Cardiac Amyloidosis Without Increased Left Ventricular Wall Thickness
Lee GY11, Kim K2, Choi JO1, Kim SJ2, Kim JS3, Choe YH4, Grogan MA5, Jeon ES6.
View PubMed
-
Acta Haematol. 2014;131(4):193-9. doi: 10.1159/000354839. Epub 2013 Nov 26. 2014
Positive Correlation between Baseline PET or PET/CT Findings and Clinical Parameters in Multiple Myeloma Patients
Park S11, Lee SJ, Chang WJ, Maeng CH, Hong JY, Choi MK, Kim YS, Jung CW, Jang JH, Kim SJ, Kim WS, Choi JY, Kim K.
View PubMed
-
Nat Genet. 2014 Apr;46(4):371-5. doi: 10.1038/ng.2916. Epub 2014 Mar 2. 2014
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
Yoo HY11, Sung MK2, Lee SH3, Kim S4, Lee H4, Park S5, Kim SC5, Lee B5, Rho K6, Lee JE6, Cho KH7, Kim W4, Ju H8, Kim J4, Kim SJ9, Kim WS9, Lee S4, Ko YH10.
View PubMed
-
Br J Haematol. 2014 Mar;164(5):745-8. doi: 10.1111/bjh.12670. Epub 2013 Nov 18. 2014
Central nervous system multiple myeloma: a different cytogenetic profile
Chang WJ11, Kim SJ, Kim K.
View PubMed
-
Hum Pathol. 2014 Mar;45(3):556-64. doi: 10.1016/j.humpath.2013.10.023. Epub 2013 Oct 31. 2014
CD798 and MYD88 mutations in diffuse Large B-cell Lymphoma
Kim Y11, Ju H2, Kim DH3, Yoo HY4, Kim SJ5, Kim WS5, Ko YH6.
View PubMed
-
Acta Haematol. 2014;131(3):156-61. doi: 10.1159/000353787. Epub 2013 Oct 31. 2014
Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP
Kim YS11, Ji JH, Ko YH, Kim SJ, Kim WS.
View PubMed
-
Ann Hematol. 2014 Mar;93(3):437-47. doi: 10.1007/s00277-013-1884-0. Epub 2013 Aug 24. 2014
Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay
Kim SJ11, Sohn I, Do IG, Jung SH, Ko YH, Yoo HY, Paik S, Kim WS.
View PubMed
-
Nutr Cancer. 2014;66(2):225-33. doi: 10.1080/01635581.2014.867065. Epub 2014 Jan 9. 2014
Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
Park S11, Han B, Cho JW, Woo SY, Kim S, Kim SJ, Kim WS.
View PubMed
-
Anticancer Res. 2014 Feb;34(2):1037-45. 2014
Prognostic Factor Analysis in Core-Binding Factor-positive Acute Myeloid Leukemia
Jung HA11, Maeng CH, Park S, Kim SJ, Kim K, Jang JH, Jung CW.
View PubMed
-
Ann Oncol. 2014 Jan;25(1):182-8. doi: 10.1093/annonc/mdt530. 2014
The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases
Hong JY11, Hong ME, Choi MK, Kim YS, Chang W, Maeng CH, Park S, Lee SJ, Do IG, Jo JS, Jung SH, Kim SJ, Ko YH, Kim WS.
View PubMed
-
Cancer Res Treat. 2014 Jan;46(1):104-7. doi: 10.4143/crt.2014.46.1.104. Epub 2014 Jan 15. 2014
Primary Follicular Lymphoma in a Male Breast: A Case Report
Jung SP11, Han KM2, Kim SJ3, Nam SJ4, Bae JW1, Lee JE4.
View PubMed
-
Ann Hematol. 2014 Jan;93(1):113-21. doi: 10.1007/s00277-013-1893-z. Epub 2013 Sep 12. 2014
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients
Kim K11, Kim SJ, Voelter V, Suh C, Yoon SS, Lee JJ, Kwak JY, Ryoo HM, Kim YS, Moon JH, Park SK, Kim SH, Mun YC, Kim JS, Eom HS, Jo DY, Jun HJ, Kim KH, Lee JO, Lee JH, Min CK; Korean Multiple Myeloma Working Party (KMMWP).
View PubMed
-
Ann Hematol. 2014 Jan;93(1):99-105. doi: 10.1007/s00277-013-1952-5. Epub 2013 Nov 16. 2014
DCEP for relapsed or refractory multiple myeloma after therapy with novel agents
Park S11, Lee SJ, Jung CW, Jang JH, Kim SJ, Kim WS, Kim K.
View PubMed
-
Acta Haematol. 2014;131(1):18-27. doi: 10.1159/000351060. Epub 2013 Sep 10. 2014
Clinical Features and Treatment Outcomes of Intravascular Large B-Cell Lymphoma: A Single-Center Experience in Korea
Hong JY11, Kim HJ, Ko YH, Choi JY, Jung CW, Kim SJ, Kim WS.
View PubMed
-
Invest New Drugs. 2013 Dec;31(6):1514-21. doi: 10.1007/s10637-013-0015-z. Epub 2013 Aug 24. 2013
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas
Kim SJ11, Kang HJ, Kim JS, Eom HS, Huh J, Ko YH, Lee J, Yim DS, Lee SY, Park WS, Yang WI, Lee SS, Suh C, Kim WS.
View PubMed
-
Amyloid. 2013 Dec;20(4):204-11. doi: 10.3109/13506129.2013.824417. Epub 2013 Aug 5. 2013
Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea
Kim SJ11, Lee GY, Jang HR, Choi JO, Kim JS, Kim HJ, Lee SY, Min JH, Jeon ES, Kim K.
View PubMed
-
Eur J Cancer. 2013 Nov;49(16):3486-96. doi: 10.1016/j.ejca.2013.07.006. Epub 2013 Aug 1. 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
Kim SJ11, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, Intragumtornchai T, Chng WJ, Cheng AL, Lim ST, Suh C, Kwong YL, Kim WS.
View PubMed
-
J Hematol Oncol. 2013 Nov 16;6:86. doi: 10.1186/1756-8722-6-86. 2013
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
Kim SJ11, Jung HA, Chuang SS, Hong H, Guo CC, Cao J, Hong XN, Suzuki R, Kang HJ, Won JH, Chng WJ, Kwong YL, Suh C, Song YQ, Zhu J, Tay K, Lim ST, Suzumiya J, Lin TY, Kim WS; Asia Lymphoma Study Group.
View PubMed
-
Lancet Oncol. 2013 Nov;14(12):e548-61. doi: 10.1016/S1470-2045(13)70450-9. 2013
Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines
Tan D11, Tan SY, Lim ST, Kim SJ, Kim WS, Advani R, Kwong YL.
View PubMed
-
Int J Hematol. 2013 Sep;98(3):346-54. doi: 10.1007/s12185-013-1403-z. Epub 2013 Jul 19. 2013
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation
Choi MK11, Kang ES, Kim DW, Ko YH, Seok H, Park JH, Pyo DH, Hoon Lim D, Kim SJ, Kim WS.
View PubMed
-
Ann Hematol. 2013 Aug;92(8):1101-10. doi: 10.1007/s00277-013-1728-y. Epub 2013 Apr 5. 2013
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia
Lee SM11, Lee WS, Shin HJ, Lee JJ, Sohn SK, Moon JH, Eom HS, Won JH, Lee KH, Lee JH, Kim DY, Yoon SS, Kim I, Jung CW, Kim SJ, Kim H, Lee JH, Ryoo HM, Lee GW, Kim SH, Mun YC, Kim MK, Joo YD; Korean Society of Hematology Adult ALL working party.
View PubMed
-
Jpn J Clin Oncol. 2013 Jun;43(6):676-80. doi: 10.1093/jjco/hyt047. Epub 2013 Apr 5. 2013
Unusual Presentation of Ewing Sarcoma in the Adrenal Gland: A Secondary Malignancy from a Survivor of Burkitt Lymphoma
Lim SH11, Lee JY, Lee JY, Kim JH, Choi KH, Hyun JY, Ko YH, Lee J, Kim SJ, Kim WS.
View PubMed
-
J Clin Oncol. 2013 Jun 10;31(17):2103-9. doi: 10.1200/JCO.2012.46.5203. Epub 2013 May 6. 2013
Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Ohmachi K11, Niitsu N, Uchida T, Kim SJ, Ando K, Takahashi N, Takahashi N, Uike N, Eom HS, Chae YS, Terauchi T, Tateishi U, Tatsumi M, Kim WS, Tobinai K, Suh C, Ogura M.
View PubMed
-
Acta Haematol. 2013;129(1):10-7. doi: 10.1159/000341284. Epub 2012 Sep 8. 2013
Isolation of Side Population Cells in B-Cell Non-Hodgkin's Lymphomas
Lee MR11, Ju HJ, Kim BS, Ko YH, Kim WS, Kim SJ.
View PubMed
-
Eur J Cancer. 2012 Nov;48(17):3223-31. doi: 10.1016/j.ejca.2012.06.003. Epub 2012 Jul 4. 2012
Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial
Kim SJ11, Yoon DH, Kang HJ, Kim JS, Park SK, Kim HJ, Lee J, Ryoo BY, Ko YH, Huh J, Yang WI, Kim HK, Min SK, Lee SS, Do IG, Suh C, Kim WS; Consortium for Improving Survival of Lymphoma (CISL) investigators.
View PubMed
-
Ann Hematol. 2012 Nov;91(11):1747-56. doi: 10.1007/s00277-012-1516-0. Epub 2012 Jun 28. 2012
Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study
Jung HA11, Park S, Cho JH, Kim S, Ko YH, Kim SJ, Kim WS.
View PubMed
-
Int J Hematol. 2012 Nov;96(5):631-7. doi: 10.1007/s12185-012-1200-0. Epub 2012 Oct 12. 2012
Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal A study by the Consortium for Improving Survival of Lymphoma (CISL)
Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Lee SI, Kang HJ, Choi CW, Park J, Song MK, Kim HJ, Kwon JH, Kwak JY, Bae SH, Park BB, Do YR, Lee HS, Jeong SH, Suh C, Kim HJ.
View PubMed
-
Blood. 2012 Oct 11;120(15):2973-80. doi: 10.1182/blood-2012-05-431460. Epub 2012 Aug 23. 2012
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Kwong YL11, Kim WS, Lim ST, Kim SJ, Tang T, Tse E, Leung AY, Chim CS.
View PubMed
-
Thromb Res. 2012 Sep;130(3):e6-12. doi: 10.1016/j.thromres.2012.03.019. Epub 2012 Apr 14. 2012
Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population
Park LC11, Woo SY, Kim S, Jeon H, Ko YH, Kim SJ, Kim WS.
View PubMed
-
J Hematol Oncol. 2012 Aug 13;5:49. 2012
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
Kim YR11, Kim JS, Min YH, Hyunyoon D, Shin HJ, Mun YC, Park Y, Do YR, Jeong SH, Park JS, Oh SY, Lee S, Park EK, Jang JS, Lee WS, Lee HW, Eom H, Ahn JS, Jeong JH, Baek SK, Kim SJ, Kim WS, Suh C.
View PubMed
-
Leuk Lymphoma. 2012 Aug;53(8):1515-24. doi: 10.3109/10428194.2012.659735. Epub 2012 Mar 1. 2012
Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group
Kim SJ11, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST, Cheng AL, Kim WS, Kwong YL.
View PubMed
-
Int J Cancer. 2012 Jul 1;131(1):235-43. doi: 10.1002/ijc.26352. Epub 2011 Aug 30. 2012
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy
Yhim HY11, Kim JS, Kang HJ, Kim SJ, Kim WS, Choi CW, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Huh J, Lee DH, Suh C, Kwak JY.
View PubMed
-
Am J Hematol. 2012 Jul;87(7):663-8. doi: 10.1002/ajh.23213. Epub 2012 May 28. 2012
Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group
Tse E11, Gill H, Loong F, Kim SJ, Ng SB, Tang T, Ko YH, Chng WJ, Lim ST, Kim WS, Kwong YL.
View PubMed
-
Leuk Lymphoma. 2012 May;53(5):807-11. doi: 10.3109/10428194.2011.635857. Epub 2011 Dec 7. 2012
Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma
Yang DH11, Kim WS, Kim SJ, Kim JS, Kwak JY, Chung JS, Oh SY, Suh C, Lee JJ.
View PubMed
-
Acta Haematol. 2012;127(3):129-34. doi: 10.1159/000333139. Epub 2012 Jan 12. 2012
Endoscopic Findings in Mantle Cell Lymphoma with Gastrointestinal Tract Involvement
Kim JH11, Jung HW, Kang KJ, Min BH, Lee JH, Chang DK, Kim YH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Kim SJ, Kim WS, Ko YH, Kim JY.
View PubMed
-
Ann Hematol. 2012 Feb;91(2):223-33. doi: 10.1007/s00277-011-1297-x. Epub 2011 Jul 26. 2012
Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)
Won YW11, Kwon JH, Lee SI, Oh SY, Kim WS, Kim SJ, Won JH, Kim KH, Park SK, Kim JS, Suh C, Yoon DH, Park JS, Kim MK, Kim H, Kang HJ, Mun YC, Kwak JY, Kim HJ, Eom HS.
View PubMed
-
Invest New Drugs. 2012 Feb;30(1):368-75. doi: 10.1007/s10637-010-9523-2. Epub 2010 Aug 24. 2012
Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity
Kim SJ11, Kim K, Park Y, Kim BS, Huh J, Ko YH, Park K, Suh C, Kim WS.
View PubMed
-
Acta Haematol. 2012;127(2):100-4. doi: 10.1159/000333113. Epub 2011 Dec 15. 2012
Primary Thyroid Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Clinical Manifestation and Outcome of a Rare Disease - Consortium for Improving Survival of Lymphoma Study
Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Kang HJ, Song MK, Kim HJ, Kwon JH, Kwak JY, Park BB, Do YR, Jeong SH, Suh C.
View PubMed
-
Leuk Lymphoma. 2012 Jan;53(1):173-5. doi: 10.3109/10428194.2011.608452. Epub 2011 Sep 23. 2012
Bone involvement in patients with stage IV diffuse large B-cell lymphoma: does it have a prognostic value
Lee HY1, Kim SJ, Kim K, Ko YH, Kim WS.
View PubMed
-
Leuk Lymphoma. 2012 Jan;53(1):19-25. doi: 10.3109/10428194.2011.603448. Epub 2011 Sep 6. 2012
B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy
Kim SJ11, Won JH.
View PubMed
-
Acta Haematol. 2011;126(2):79-86. doi: 10.1159/000327255. Epub 2011 May 4. 2011
Pretreatment Serum Level of 15-kDa Granulysin Might Have a Prognostic Value in Patients with Diffuse Large B Cell Lymphoma
Park Y11, Choi YJ, Park SJ, Lee SR, Sung HJ, Park KH, Kim SJ, Choi CW, Jung KY, Kim BS.
View PubMed
-
J Hematol Oncol. 2011 Aug 15;4:34. doi: 10.1186/1756-8722-4-34. 2011
Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy
Kim YR11, Kim JS, Kim SJ, Jung HA, Kim SJ, Kim WS, Lee HW, Eom HS, Jeong SH, Park JS, Cheong JW, Min YH.
View PubMed
-
BMC Cancer. 2011 Jul 29;11:321. doi: 10.1186/1471-2407-11-321. 2011
Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
Kim SJ11, Choi CW, Mun YC, Oh SY, Kang HJ, Lee SI, Won JH, Kim MK, Kwon JH, Kim JS, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Lee JH, Oh S, Park KW, Suh C, Kim WS.
View PubMed
-
Ann Hematol. 2011 May;90(5):539-46. doi: 10.1007/s00277-010-1104-0. Epub 2010 Oct 20. 2011
Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma
Kim SJ11, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C.
View PubMed
-
Jpn J Clin Oncol. 2011 Mar;41(3):353-7. doi: 10.1093/jjco/hyq194. Epub 2010 Oct 14. 2011
Low-dose Acyclovir is Effective for Prevention of Herpes Zoster in Myeloma Patients Treated with Bortezomib: A Report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study
Kim SJ11, Kim K, Do YR, Bae SH, Yang DH, Lee JJ.
View PubMed
-
Ann Oncol. 2011 Feb;22(2):411-6. doi: 10.1093/annonc/mdq393. Epub 2010 Aug 2. 2011
Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients
Kim MK11, Suh C, Lee DH, Min CK, Kim SJ, Kim K, Moon JH, Yoon SS, Lee GW, Kang HJ, Kim SH, Choi CW, Eom HS, Kwak JY, Kim HJ, Mun YC, Bang SM, Lee K, Shin HJ, Lee JH; Korean Multiple Myeloma Working Party.
View PubMed
-
Blood. 2011 Feb 10;117(6):1958-65. doi: 10.1182/blood-2010-06-288480. Epub 2010 Dec 9. 2011
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone
Kim SJ11, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon JH, Mun YC, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Park J, Oh S, Huh J, Ko YH, Suh C, Kim WS.
View PubMed
-
Leuk Lymphoma. 2011 Feb;52(2):317-20. doi: 10.3109/10428194.2010.529203. Epub 2010 Nov 11. 2011
Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy
Yi JH1, Kim SJ, Ko YH, Kim WS.
View PubMed
-
Leuk Lymphoma. 2011 Feb;52(2):205-13. doi: 10.3109/10428194.2010.542261. 2011
Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis
Kim JA11, Kim SJ, Do IG, Jin J, Nam DH, Ko YH, Kim K, Kim WS.
View PubMed
-
Jpn J Clin Oncol. 2010 Dec;40(12):1147-53. doi: 10.1093/jjco/hyq111. Epub 2010 Jul 20. 2010
Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients
Seo HY11, Park JM, Park KH, Kim SJ, Oh SC, Kim BS, Kim YH, Kim JS.
View PubMed
-
Int J Hematol. 2010 Dec;92(5):690-6. doi: 10.1007/s12185-010-0720-8. Epub 2010 Nov 18. 2010
Treatment of localized extranodal NK/T cell lymphoma, nasal type
Kim SJ11, Kim WS.
View PubMed
-
Cancer Genet Cytogenet. 2010 Dec;203(2):215-21. doi: 10.1016/j.cancergencyto.2010.08.022. 2010
GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization
Koh Y11, Kim DY, Park SH, Jung SH, Park E, Kim HJ, Sohn SK, Joo YD, Kim SJ, Shin HJ, Kim SH, Song HS, Chung J, Kim I, Yoon SS, Kim BK, Shin SH, Chung YJ, Park S.
View PubMed
-
Haematologica. 2010 Nov;95(11):1935-42. doi: 10.3324/haematol.2010.026104. Epub 2010 Jul 27. 2010
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
Kim SJ11, Lee JW, Jung CW, Min CK, Cho B, Shin HJ, Chung JS, Kim H, Lee WS, Joo YD, Yang DH, Kook H, Kang HJ, Ahn HS, Yoon SS, Sohn SK, Min YH, Min WS, Park HS, Won JH.
View PubMed
-
Cancer Sci. 2010 Nov;101(11):2443-7. doi: 10.1111/j.1349-7006.2010.01698.x. 2010
Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study
Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Kang HJ, Choi CW, Park J, Kim HJ, Kwon JH, Lee HS, Lee GW, Eom HS, Kwak JY, Suh C, Kim HJ.
View PubMed
-
J Bone Miner Metab. 2010 Nov;28(6):713-8. doi: 10.1007/s00774-010-0203-2. Epub 2010 Jul 6. 2010
Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate
Yang KH11, Park SY, Park SW, Lee SH, Han SB, Jung WK, Kim SJ.
View PubMed
-
Qual Life Res. 2010 Oct;19(8):1097-103. doi: 10.1007/s11136-010-9670-0. Epub 2010 May 5. 2010
Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma
Kim BJ11, Park HR, Roh HJ, Jeong DS, Kim BS, Park KW, Cho SC, So YT, Oh SY, Kim SJ.
View PubMed
-
Int J Hematol. 2010 Oct;92(3):510-7. doi: 10.1007/s12185-010-0680-z. Epub 2010 Sep 14. 2010
Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study
Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Kang HJ, Choi CW, Park J, Kim HJ, Kwon JH, Lee HS, Lee GW, Eom HS, Kwak JY, Lee WS, Suh C, Kim HJ.
View PubMed
-
Ann Hematol. 2010 Oct;89(10):1011-8. doi: 10.1007/s00277-010-0978-1. Epub 2010 May 7. 2010
Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea
Won YW11, Kim SJ, Kim K, Ko YH, Kim WS.
View PubMed
-
Leuk Res. 2010 Sep;34(9):1175-9. doi: 10.1016/j.leukres.2010.02.010. Epub 2010 Mar 5. 2010
Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report
Yun J11, Kim SJ, Won JH, Choi CW, Eom HS, Kim JS, Kim MK, Kwak JY, Kim WS, Suh C.
View PubMed
-
Hematol Oncol. 2010 Jun;28(2):57-61. doi: 10.1002/hon.905. 2010
F-18-FDG uptake and its clinical relevance in primary gastric lymphoma
Yi JH11, Kim SJ, Choi JY, Ko YH, Kim BT, Kim WS.
View PubMed
-
BMC Cancer. 2010 Jun 22;10:321. doi: 10.1186/1471-2407-10-321. 2010
Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
Yhim HY11, Kang HJ, Choi YH, Kim SJ, Kim WS, Chae YS, Kim JS, Choi CW, Oh SY, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Lee JJ, Sung HJ, Kim HJ, Lee DH, Suh C, Kwak JY.
View PubMed
-
Int J Hematol. 2010 Jun;91(5):886-91. doi: 10.1007/s12185-010-0580-2. Epub 2010 May 8. 2010
A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation
Kim ST11, Lee MH, Kim SY, Kim SJ, Kim DH, Jang JH, Kim K, Kim WS, Jung CW.
View PubMed
-
Ann Oncol. 2010 May;21(5):1058-63. doi: 10.1093/annonc/mdp412. Epub 2009 Oct 22. 2010
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type
Kim SJ11, Oh SY, Hong JY, Chang MH, Lee DH, Huh J, Ko YH, Ahn YC, Kim HJ, Suh C, Kim K, Kim WS.
View PubMed
-
Am J Hematol. 2010 May;85(5):362-3. doi: 10.1002/ajh.21663. 2010
Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission
Au WY1, Kim SJ, Yiu HH, Ngan RK, Loong F, Kim WS, Kwong YL.
View PubMed
-
Bone Marrow Transplant. 2010 Apr;45(4):801-2. doi: 10.1038/bmt.2009.240. Epub 2009 Sep 21. 2010
Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma
Lee SC1, Kim SJ, Lee DH, Kim WS, Suh C, Won JH.
View PubMed
-
Invest New Drugs. 2010 Apr;28(2):171-7. doi: 10.1007/s10637-009-9260-6. Epub 2009 May 7. 2010
Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial
Oh SY11, Kim WS, Lee DH, Kim SJ, Kim SH, Ryoo BY, Kang HJ, Choi YJ, Chung JS, Kim HJ, Suh C.
View PubMed
-
Int J Hematol. 2010 Apr;91(3):456-63. doi: 10.1007/s12185-010-0536-6. Epub 2010 Mar 3. 2010
Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients
Ahn HK11, Kim SJ, Yun J, Yi JH, Kim JH, Won YW, Kim K, Ko YH, Kim WS.
View PubMed
-
Cancer Genet Cytogenet. 2010 Mar;197(2):117-21. doi: 10.1016/j.cancergencyto.2009.11.008. 2010
Molecular cytogenetic analysis of Korean patients with Waldenstrom macroglobulinemia
Bang SM11, Seo JW, Park KU, Kim SJ, Kim K, Kim SH, Cho SR, Kim HC, Song J, Kim JS, Kim KH, Lee JH, Lee JJ, Shin MG, Suh C, Chi HS, Oh DY, Won JH, Kim HJ, Yoon SS, Lee DS; Korean Multiple Myeloma Working Party (KMMWP).
View PubMed
-
Leuk Res. 2010 Mar;34(3):294-300. doi: 10.1016/j.leukres.2009.08.024. Epub 2009 Sep 16. 2010
The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease
Park Y11, Kim DS, Park SJ, Seo HY, Lee SR, Sung HJ, Park KH, Choi IK, Kim SJ, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
View PubMed
-
Med Oncol. 2010 Mar;27(1):91-7. doi: 10.1007/s12032-009-9178-z. Epub 2009 Feb 24. 2010
Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer
Kim SJ11, Rabbani ZN, Dong F, Vollmer RT, Schreiber EG, Dewhirst MW, Vujaskovic Z, Kelley MJ.
View PubMed
-
Ann Hematol. 2010 Feb;89(2):201-6. doi: 10.1007/s00277-009-0807-6. Epub 2009 Aug 25. 2010
Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
Koh Y11, Bang SM, Lee JH, Yoon HJ, Do YR, Ryoo HM, Lee N, Kim SJ, Kim K, Yoon SS, Won JH, Mun YC, Lee MH, Rhee KH, Kim HJ, Eom H, Kim MK, Shin HC; Korean Multiple Myeloma Working Party.
View PubMed
-
J Clin Oncol. 2010 Feb 1;28(4):e54-5. doi: 10.1200/JCO.2009.23.7560. Epub 2009 Nov 16. 2010
Gastric Recurrence of Extramedullary Granulocytic Sarcoma After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Choi ER11, Ko YH, Kim SJ, Jang JH, Kim K, Kang WK, Jung CW, Kim DH.
View PubMed
-
Echocardiography. 2010 Feb;27(2):E23-6. doi: 10.1111/j.1540-8175.2009.01059.x. 2010
Primary Angiosarcoma of the Pulmonary Trunk Mimicking Pulmonary Thromboembolism
Kim JB11, Kim SH, Lim SY, Roh SY, Cho GY, Song HJ, Park S, Lee J, Kim SJ.
View PubMed
-
J Clin Oncol. 2009 Dec 10;27(35):6027-32. doi: 10.1200/JCO.2009.23.8592. Epub 2009 Nov 2. 2009
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Kim SJ11, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, Kim WS.
View PubMed
-
Acta Haematol. 2010;123(1):48-54. doi: 10.1159/000262291. Epub 2009 Dec 2. 2009
Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphomas Involving Rare Extranodal Sites: A Single-Center Experience
Yun J11, Kim SJ, Kim JA, Kong JH, Lee SH, Kim K, Ko YH, Kim WS.
View PubMed
-
Ann Hematol. 2009 Nov;88(11):1099-106. doi: 10.1007/s00277-009-0729-3. Epub 2009 Mar 14. 2009
Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea
Choi MK11, Jun HJ, Lee SY, Kim KH, Lim do H, Kim K, Ko YH, Kim WS, Kim SJ.
View PubMed
-
Acta Haematol. 2009;122(4):200-10. doi: 10.1159/000253027. Epub 2009 Oct 29. 2009
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry
Kim SJ11, Kim K, Kim BS, Jo DY, Kang HJ, Kim JS, Mun YC, Kim CS, Sohn SK, Eom HS, Kwak JY, Shim H, Yoon HJ, Jin JY, Min CK, Shin H, Won JH, Lee JJ, Kwon JH, Joo YD, Do YR, Kim SH, Oh S, Suh C, Lee J, Yoon SS, Kim MK, Bang SM, Ryoo HM, Kim BS, Kim H, Kim HJ, Kim YS, Park CW, Lee GW, Shin HJ, Park SK, Park JS, Kim HY, Lee DS, Lee JH; Korean Multiple Myeloma Working Party.
View PubMed
-
Leuk Lymphoma. 2009 Jul;50(7):1119-25. doi: 10.1080/10428190902926999. 2009
Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea
Chang MH11, Kim SJ, Kim K, Oh SY, Lee DH, Huh J, Ko YH, Choi CW, Yang DH, Won JH, Kim WS, Suh C.
View PubMed
-
Cancer Res Treat. 2009 Jun;41(2):104-7. doi: 10.4143/crt.2009.41.2.104. Epub 2009 Jun 30. 2009
Complete Remission in a Patient with Human Herpes Virus-8 Negative Multicentric Castleman Disease Using CHOP Chemotherapy
Seo HY11, Kim EB, Kim JW, Shin BK, Kim SJ, Kim BS.
View PubMed
-
Med Oncol. 2009;26(1):45-8. doi: 10.1007/s12032-008-9079-6. Epub 2008 Jun 10. 2009
Rituximab-induced acute thrombocytopenia: a case report and review of the literature
Yi JH11, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS.
View PubMed
-
Ann Oncol. 2009 Feb;20(2):390-2. doi: 10.1093/annonc/mdn726. 2009
Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study
Kim SJ1, Kim K, Kim BS, Suh C, Huh J, Ko YH, Kim WS.
View PubMed
-
Acta Haematol. 2008;120(4):211-6. doi: 10.1159/000193223. Epub 2009 Jan 20. 2008
Increased Serum 90K and Galectin-3 Expression Are Associated with Advanced Stage and a Worse Prognosis in Diffuse Large B-Cell Lymphomas
Kim SJ11, Lee SJ, Sung HJ, Choi IK, Choi CW, Kim BS, Kim JS, Yu W, Hwang HS, Kim IS.
View PubMed
-
Eur J Haematol. 2008 Sep;81(3):177-84. doi: 10.1111/j.1600-0609.2008.01099.x. Epub 2008 May 27. 2008
Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy
Kim SJ11, Lee SJ, Choi IY, Park Y, Choi CW, Kim IS, Yu W, Hwang HS, Kim BS.
View PubMed
-
Leuk Lymphoma. 2008 Aug;49(8):1623-6. doi: 10.1080/10428190802129934. 2008
Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: Does it have a prognostic value
Park Y1, Kim SJ, Lee SJ, Kim BS.
View PubMed
-
Clin Lymphoma Myeloma. 2008 Aug;8(4):237-40. doi: 10.3816/CLM.2008.n.031. 2008
Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma
Kim SJ11, Kim K, Kim BS, Lee HJ, Kim H, Lee NR, Nam SH, Kwon JH, Kim HJ, Sohn SK, Won JH, Lee JH, Suh C, Yoon SS, Kim HJ, Kim I, Do YR, Lee WS, Joo YD, Shin HJ; Korean Multiple Myeloma Working Party.
View PubMed